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ABSTRACT OF THE DISSERTATION 
Directed Differentiation and Characterization of V3 Spinal Interneruons from Mouse Embryonic 
Stem Cells 
by 
Hao Xu 
Doctor of Philosophy in Biomedical Engineering 
Washington University in St. Louis, 2015 
Professor Shelly Sakiyama-Elbert, Chair 
 
Neuronal populations involved in locomotion controlling central pattern generators 
within the spinal cord hold great potential for spinal cord injury therapy.  Spontaneous recovery 
in rodent models suggests that a population that can reorganize around an injury site could be 
useful for functional recovery therapeutics after spinal cord injury. The glutamatergic, 
commissural, long-extending V3 interneurons shown to balance locomotor rhythm regularity and 
robustness within central pattern generators in vivo are both an ideal population for spinal cord 
injury therapeutics and a vital population to study as a part of locomotor circuitry. Unfortunately, 
due to the scarcity of these cells in the spinal cord, in vitro studies of dissociated V3 interneurons 
are technically challenging.  Embryonic stem cells provide a bountiful cell source for the study 
of different cell types and regenerative medicine. While there are extensive reports on mouse 
embryonic stem cell derived spinal motoneurons, many other spinal neuronal populations have 
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not been derived. This dissertation focuses on the induction and characterization of V3 INs from 
embryonic stem cells.  In the first study, an induction protocol for V3 interneurons from mouse 
embryonic stem cells was established.  A motoneuron protocol was driven towards a more 
ventral fate by lowering retinoic acid concentration during induction and increasing the induction 
duration of morphogen sonic hedgehog signaling. In the second study, a selectable V3 
interneuron cell line was generated by knocking the puromycin resistance enzyme, puromycin N-
acetyltransferase, into the Sim1 locus on one allele within the mouse genome, allowing native 
Sim1 gene regulatory elements to drive puromycn N-acetyltransferase expression. Puromycin 
selection highly enriched for the V3 interneuron population, allowing the cultures to be 
characterized by electrophysiology and immunocytochemistry. Selected cells survived for four 
weeks and exhibited synaptic function as well as glutamatergic marker expression. This work 
establishes a method and a tool for high throughput, low labor acquisition of V3 interneurons for 
future studies. 
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Chapter 1: Introduction 
1.1 Overview 
The purpose of this thesis is to develop methods to better study spinal V3 interneurons 
(INs) for basic research and developing cell-based therapeutics. In murine models of spinal cord 
injury (SCI), spontaneous functional recovery had been observed and traditionally attributed to 
axonal sprouting through the injury site. However, recent studies suggest that this recovery may 
actually be due to new relay networks of propriospinal neurons formed around the injury[1-3]. 
This reorganization suggests that for designing more effective cell-based SCI treatments, a 
propriospinal relay population, particularly long extending propriospinal populations may yield 
better functional recovery than employing a single end target neuronal population (e.g. 
motoneurons (MNs)) [2]. V3 INs are excitatory glutamatergic, long extending spinal neurons 
which can cross the midline (commissural) and synapse onto multiple cell types (including 
motorneurons and other INs) [4]. They are part of the central pattern generator (CPG) circuitry 
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and are involved in locomotor rhythm generation, making them attractive candidates for cell 
based neuro-regenerative therapies [4]. To explore this hypothesis, it is necessary to obtain a 
sizable and relatively pure population of V3 INs for study. However, V3 INs only comprise ~10% 
of the ventral spinal population[5], making their isolation tedious and inefficient. Therefore, this 
thesis addresses that need by providing a high throughput, low labor method to obtain V3 INs 
from mouse embryonic stem cells (mESCs).  
The first aim of this thesis introduces a differentiation protocol for the induction of V3 
INs from mESCs. Using a previously established MN induction protocol as a starting point [6], 
Shh and RA exposure was varied in a six and eight day induction protocol to identify the best 
conditions for V3 IN induction. The induced cultures up-regulated Sim1 and Nkx2.2 mRNA 
expression and stained positive for post-mitotic V3 marker Uncx and progenitor markers Nkx2.2 
and Ngn3. This work provided a scalable and simple way to generate V3 INs from mESCs.  
The second aim of this thesis is to generate and characterize a puromycin selectable V3 
cell line for better identification and study. Using recombineering techniques [7], a puromycin 
resistance gene was knocked into the Sim1, a V3 marker, locus of a mESC line. This allowed 
Sim1’s gene regulatory elements to control puromycin resistance gene expression thus making 
the cells drug selectable. This cell line yielded a highly enriched V3 population after puromycin 
selection as shown by Sim1 expression. The Sim1 expressing cells matured into VGluT2+ 
neurons that expressed synaptic markers.  
The following introduction will provide necessary information and history to better 
understand this project and its significance. Stem cells, the populations of the ventral spinal cord, 
and various genomic engineering techniques will be discussed.   
3 
 
 
1.2 Stem Cells 
Pluripotent stem cells hold great potential for regenerative medicine, drug discovery, and 
basic developmental research. While they exist only transiently during development in the native 
blastocyst, these cells can be isolated and cultured indefinitely under proper laboratory 
conditions [8,9]. Their potential to renew indefinitely and become any cell type within the body 
makes them a limitless cell source for research and cell-based therapeutics. Numerous 
differentiation protocols have been established for different types of pluripotent stem cells. This 
section overviews the history and types of pluripotent stem cells.  
 
1.2.1 Mouse Embryonic Stem Cells 
Early attempts at isolating pluripotent embryonic stem cells from the mouse embryo for 
long term culture were unsuccessful [9].  Prior to 1981, mouse embryonic carcinoma cells were 
the only pluripotent cells available [8]. Unfortunately, as cancer cells, they did not have a normal 
karyotype. In 1981, mESC culture was first reported by Evans and Kaufman [9]. By comparing 
the protein expression of embryonic carcinomas and cells isolated during different stages of early 
development, the timing for mESC appearance was determined. The resulting cells were cultured 
in embryonic carcinoma cell conditioned media and resembled embryonic carcinoma cells as 
they also formed teratomas but, unlike embryonic carcinoma cells, had a completely normal 
karyotype [9]. Originally, mESCs were cultured on mitomycin-C inactivated fibroblast feeder 
layers. However, regulatory factors differentiation inhibitory activity (DIA) and leukemia 
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inhibition factor (LIF) were identified for the maintenance of mESCs [10,11], such that feeder 
layers were no longer needed.   
 
1.2.2 Human Embryonic Stem Cells 
Following the success of mESCs, primate ESC cultures [12] and human embryonic stem 
cell cultures using cells from discarded in vitro fertilization embryos [13] were established. 
These human stem cells, like mESCs, were derived from early stage embryos and had the ability 
to differentiate into cells from all three germ layers. These cells could grow for 3-4 months 
without losing their undifferentiated morphology. Unfortunately, LIF, which was sufficient to 
maintain murine lines, was not sufficient to suppress spontaneous differentiation of human ESCs 
[14]. A combination of either Activin or Nodal and FGF2 was necessary for maintaining hESC 
pluripotency [15]. This was an important move because an animal-derived feeder layer or even a 
animal feeder layer based conditioned media for culturing cells were not animal-product free and 
chemically defined and were thus not acceptable for clinical applications [15]. While the 
establishment of hESC culture was a step forward in stem cell research, ethical concerns about 
their origin and use have resulted in a limitation of federal funding on hESC research in 2001 
[16]. While that policy has since been overturned[17], the moral controversy surrounding hESCs 
still remain.  
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1.2.3 Induced Pluripotent Stem Cells (iPSC) 
Due to the ethical and immunogenic concerns of hESCs, a different pluripotent cell 
source was needed. Early frog cloning and the successful cloning of Dolly the sheep showed that 
reprogramming of somatic nuclei could be achieved and, specifically, in mammals [18,19]. 
Additionally, Davis et al.’s conversion of fibroblasts into muscle lineage cells by MyoD 
transcription factor transduction showed that cell fates could be changed by transcription factor 
expression [20]. These observed somatic and transcription factor based reprogramming 
capacities were the beginning for achieving a new pluripotent cell source [21]. These efforts 
culminated in Shinya Yamanaka’s 2006 discovery that overexpression of 4 factors (Oct3/4, Sox2, 
Klf4, c-Myc, collectively called the Yamanaka factors) can convert fully differentiated murine 
cells back into an induced pluripotent state [22]. The resulting stem cells formed teratomas and 
had similar morphology, gene expression, and DNA methylation profiles as ESCs. Two years 
after the first iPSCs were reported, the same process was successfully repeated with human 
fibroblasts [23].  
Many methods can be used to derive iPSCs. The original method delivered the Yamanaka 
factor by retroviral transduction [22,23]. This resulted in integration of the Yamanaka factor 
carrying vector into the genome. Currently, multiple integration-free methods exist, such as the 
use of plasmids[24], RNA-based Sendai virus [25], synthesized mRNAs[26] and even the direct 
delivery of proteins[27]. This wide variety of methods for obtaining integration free iPSCs 
provided the next step towards translational work.  
Great expectations were placed on iPSCs because they could be generated from patients’ 
fibroblasts and thus bypass immunogenicity concerns for transplantation. Unfortunately, there 
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are still concerns over the safety of iPSCs for therapeutics. Epigenetic abnormalities[28,29], 
potential tumorigenecity[30,31], and immunogenicity[32] are all causes for concern. These 
issues provide significant hurdles for transplantation.  
 
1.2.4 Heterogeneity after stem cell differentiation 
The establishment of pluripotent cells opened up the possibility of deriving populations 
from a self-renewing cell population. While stem cell differentiation protocols are able to 
generate desired populations, these processes also result in heterogeneity of the final population. 
During any differentiation process, the proportion of cells that fully undergo differentiation is 
never 100%. The end population may contain some cells that are post-mitotic and cells that are 
still undergoing active mitosis. In some cases, the mitotic cells (e.g. undifferentiated pluripotent 
cells) can overtake the desired post-mitotic population. For example, during transplantation 
therapies using animal models, undifferentiated cells can result in the over proliferation of cells 
and even result in teratomas [33]. In spinal cord therapy studies, undifferentiated ESCs  have 
been observed to over-proliferate and abolish initial function recovery [34]. Undesired 
proliferating populations could also result in cell masses in undesired locations [35]. This issue 
of heterogeneity needs to be addressed before any form of pluripotent stem cells can be used for 
transplantation therapeutics.  
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1.3 Ventral Spinal Neuron Populations 
Developmental analysis of the spinal cord has been helpful for understanding locomotion 
circuitry.  Eleven progenitor populations have been designated within the developing spinal cord: 
six dorsal and five ventral populations [36]. Many studies have focused on how different 
populations of spinal cord neurons arise, migrate, mature, and integrate themselves into the 
mature spinal cord. In particular, the ventral populations have been implicated in the function of 
major locomotor pathways.  
During spinal cord development, the ventral neural tube is patterned by Shh released 
from the notochord, which is situated ventral to the neural tube [37-41]. Shh diffuses dorsally 
such that the more ventral the population, the greater the required Shh signal magnitude and 
duration[38]. Two classes of homeodomain proteins (class I and II) respond to the graded Shh 
signaling. Class I proteins are repressed by a specific Shh threshold and define the ventral 
boundaries of their progenitor domains while class II proteins require certain Shh thresholds to 
activate and define the dorsal boundaries of their progenitor domains [42]. These two classes of 
proteins interact to form the sharp progenitor domain boundaries. This morphogen gradient 
based determination of distinct cell types is often referred to as the French flag model [43]. 
While there is new evidence that the French-flag-like pattern is established partially by cell 
migration and sorting [44], the resulting banded pattern nonetheless characterizes the five ventral 
spinal progenitor populations: V0-V3 and MNs. 
Two driving motivations for understanding ventral populations are understanding CPGs 
and deriving cell populations for spinal cord injury therapeutics. CPGs have been studied from 
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both a development based molecular marker perspective, with the use of genetically engineered 
mice [4,45], and from an anatomic perspective where the function of different neuronal types are 
assessed in the context of their connectivity [46-48]. Unfortunately, not all cells identified by 
their molecular markers have their roles characterized in the mature spinal cord. Likewise, the 
origin of every spinal neuronal population within the mature spinal cord is not well established. 
However, by studying CPGs from both anatomic and molecular marker perspectives, 
understanding of the development and function of CPGs can be achieved.  
This section will be an overview of all five neuron classes in the ventral spinal cord. 
Background including progenitor and post-mitotic markers will be discussed as well as their 
roles within CPG. While this section is organized by the five neuronal classes, it should be 
emphasized that this is not the only way to understand and organize populations involved in 
CPGs and locomotion control. The choice in presenting the ventral spinal populations in this way 
is to provide appropriate context for the understanding the V3 INs from the perspective of this 
thesis, where V3 INs are generated and targeted by looking at molecular markers.  
 
1.3.1 V0 INs 
V0 INs arise in the middle of the neural tube and are the dorsal most population 
belonging to the ventral spinal cord[36]. The progenitor p0 population is marked by the 
transcription factor Dbx1[49]. As the V0 population matures, Evx1 is turned on in a subset of the 
V0 population, known as the V0V population [49,50]. The Dbx1
+ cells that do not express Evx1 
are termed V0Ds. Almost all V0Vs have been reported to be excitatory while V0Ds are 
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approximately 50% GABAergic and 70% glycine-expressing. This greater than 100% total 
indicates a significant overlap of GABAergic and glycine expressing V0Ds.   
V0Vs and V0Ds have been studied for their role in locomotion. Both populations receive 
primary afferent excitatory signaling, innervation from seratonergic fibers, and synapse onto 
contralateral MNs [51]. Ablation of both populations resulted in synchronized locomotion 
activity [52,53]. The V0Ds are responsible for slow locomotion alternation while V0Vs are 
responsible for alternation at medium and fast speeds [53]. The current understanding of the V0 
IN population is that V0Vs are involved in left-right locomotion by activating contralateral 
inhibitory INs that inhibit MNs while V0Ds modify locomotion based on sensory inputs. 
Two other V0 populations, cholinergic V0Cs and glutamatergicV0Gs both arise around 
e11.5 from a small neuronal population that expresses Pitx2 [54]. This population is 
predominantly projects ipsilaterally While Zagoraiou et al. mention V0Gs and identify their 
glutamatergic nature, their primary focus was on the significance of V0Cs as the source of 
cholinergic input to MNs. V0Cs been shown to fire in phase with MNs, indicating their 
recruitment within the same circuitry as MN activation. In mice where V0cs do not express the 
acetylcholine synthetic enzyme, choline acetyl transferase, mice are unable to enhance their 
muscle activation, indicating that V0cs modulate MN control of muscles [54]. The discovery of 
V0Cs elucidated the role of cholinergic input onto MNs.  
 A diverse set of INs arise from the p0 progenitor domain. This diversity indicates 
that molecular and lineage based ways of characterizing INs may overgeneralize a population. 
However, the identification of different V0 subpopulation specific molecular markers also 
indicates how powerful this method is in understanding the signals involved in IN specification.   
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1.3.2 V1 INs 
V1 INs are located just ventral to V0s in the ventral spinal population. V1 INs arise from 
the p1 progenitor domain which expresses Pax6, Dbx2, and Nkx6.2 [36]. Post-mitotic V1 INs 
most notably express En1, FoxD3, and Lhx2, with a sub population expressing Foxp2 [55]. V1 
INs have been shown to be required for faster locomotion frequencies. In animals without V1 
INs, the amount of time needed for a cycle of steps was lengthened from 3-4s to about 8s [56].  
Even though not all populations derived from V1 INs have been identified, two notable 
inhibitory sub-populations arise from V1 INs: Renshaw cells and IaINs.  Renshaw cells, first 
identified in 1946, mediate inhibition of MNs coupled to either extensor or flexor motor pools 
[57].  IaINs, identified in 1956, contribute to inhibition of motor pools due to input from Ia 
sensory inputs from the muscle [58].  These two cell types work together to regulate ipsilateral 
muscle activity during locomotion. While these two populations can be identified by 
physiological function alone, mature V1 INs can also be distinguished by their expression of 
calcium buffering proteins. Renshaw cells tend to display strong calbindin expression and 
weakly express parvalbumin while mature V1 IaINs only express parvalbumin. Furthermore, all 
Renshaw cells arise from the V1 domain [59,60] but not all IaINs are V1 IaINs [59,61], 
indicating that there is more than one developmental source of IaINs.  
Renshaw cells and V1 IaINs enter the post-mitotic state at different points in time. 
Renshaw cells arise from an earlier V1 population (e10.5). They are identified by MafB (note 
that MafB is also present in MNs and other dorsal populations) after entering the post-mitotic 
stage and during migration. V1 IaINs arise from a later born V1 population which is positive for 
FoxP2 (e11.5) [55]. Although different V1 populations express MafB and FoxP2, neither is 
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unique to V1 INs and thus neither control the differentiation process into V1 population [55]. It 
has been shown that Pax6 and En1 regulate Renshaw cell development [60], but what is 
responsible for differentiating these cell types and other V1 INs is still unknown.  
The study of V1 IN maturation has revealed a complex maturation process. Early on in 
development, the reciprocal inhibitions of IaINs are present but weakly acting. Maturation of the 
circuitry most likely occur later corresponding to when an animal develops better locomotion 
control [61]. Studies looking at the establishment of CPGs before birth have indicated that 
Renshaw cells and V1 IaINs are organized before birth but only during maturation do specific 
synapses stabilize or weaken as stable and coordinated locomotion is established [61].  
The study of V1 INs proved great insight into the diversification of an IN population. The 
fact that IaINs come from more than the V1 domain indicates a level of redundancy in IN 
maturation. Additionally, timing difference in Renshaw cell and V1 IaIN post-mitotic 
commitment indicates that in addition to Shh and RA gradients, a temporal factor is also play. 
These studies further expose the complexity of spinal and CPG development.  
 
1.3.3 V2 INs 
V2 INs are the third most ventral spinal population, located just dorsal to the MN domain 
[36,39]. Lhx-3 expressing progenitor p2 cells give rise to two main populations of V2 INs: V2a 
INs and V2b INs [62,63]. V2as are marked by the post-mitotic transcription factor marker Chx10 
while V2b INs are marked by the transcription factor Gata3[63]. A third and fourth population, 
identified by Sox1 and Shox2 respectively, have been recently identified [64,65]. 
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V2a INs are glutamatergic ipsilateral INs that are able to synapse onto MNs. They are 
involved in regulating breathing as well as left-right locomotion[66]. They have also recently 
been shown to be involved in forelimb reaching motions [67]. The precursor population to V2a 
INs also generates V2b INs. During differentiation, Notch activity contributes to V2a/ V2b cell 
fate determination [68,69]. Notch activation drives V2b formation while inhibition of notch 
results in V2a INs. Inhibitory V2b INs are involved in ipsilateral flexor-extensor coordination 
[70].  
 Sox1+ V2c INs are very similar to V2b INs and become V2b INs in the absence of Sox1. 
Shox2+ V2d INs have a marked overlap with Chx10+ V2a INs [64]. V2ds have been shown to be 
ipsilaterally projecting onto ipsilaterally and commissurally extending cells and are most likely 
involved in the stabilization of locomotor frequency[65].   
The different functions of V2a INs at different levels of the spinal cord indicate their 
roles in many aspects of motor function, making them another good target for better 
understanding CPGs and for spinal cord injury therapeutics. As seen by the V2b IN also being 
involved in flexor-extensor coordination, there may be some overlap in cell type function within 
the spinal cord.  This could also be true for cell types involved in functional recovery. Thus, our 
lab is also investigating V2a INs in addition to the V3 INs reported in this thesis. 
 
1.3.4 MNs 
MNs are the second most ventral spinal population. As their name indicates, MNs are not 
considered interneurons; however, MNs are very important for locomotor function and are often 
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the direct synaptic targets of the interneuron populations. MNs arise from the Olig2 expressing 
pMN domain, which also gives rise to astrocytes and oligodendrocytes [71,72]. Post-mitotic 
MNs express Hb9 and Isl1 [73,74]. As MNs mature, they organize into rostral-caudal columns 
and cluster into pools that further specify their function within motor circuits. In fact, this highly 
predictable organization was first observed by George Romanes in 1941 and later elaborated 
upon in 1951[75]. This organization is positioned consistently along the rostral-caudal, dorsal-
ventral, and medio-lateral axes of the spinal cord. The rostral-caudally organized columnar 
identities specify where they settle and which muscles they innervate [76-79]. Furthermore, 
within the columns, the neurons that innervate muscle groups with synergistic effects are also 
grouped together in pools [80,81]. This observed rostral-caudal patterning has been shown to be 
regulated by Hox genes which are patterned by a combination of Fgfs, Gdf11, and retinoid 
signaling [82]. Much work has been done to understand the molecular pathways involved in MN 
specification [83]. Lim homeodomain factors (Lhx3 and Lhx4), the Hox cofactor FoxP1, and 
many other molecular markers help specify MN subtype fate [84,85]. This further differentiation 
of MNs into subtypes is vital to motor control, especially the finer aspects of motor control due 
to their predictable and specific projections on to muscles.  
One experiment found that MNs could be stripped of their columnar and pool 
organization by mutating FoxP1. In these mutants, there are only some MNs that project 
similarly to wildtype. Analysis of sensory input showed that appropriate sensory input was 
present only in the MNs that project in a similar manner as wildtype [86]. This indicates that 
sensory feedback synapse formation is independent of MN positioning but MN positioning is 
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vital for proper sensory feedback.  This finding is important because it sheds light on the 
feedback process, without which, results in severely uncoordinated movements in animals [87].  
1.3.5 V3 INs 
V3 INs arise from the most ventral progenitor domain of the ventral spinal cord, the p3 
domain. Marked by Ngn3 and Nkx2.2, p3 progenitor cells mature into Sim1 and Uncx 
expressing V3 INs [4,36,88,89]. A great majority of V3 INs project commissural axons with a 
few (<15%) projecting axons ipsilaterally [4]. There are even V3 INs that project to both halves 
of the spinal cord [4].  V3 INs have been shown to project onto many locomotor cell types, 
including MNs, IaINs, V2 INs, and Renshaw cells, indicating the importance of V3 excitatory 
input for many aspects of locomotion [4].  
V3 INs are involved in locomotion rhythm bursting and symmetry during walking. 
Fictive locomotor studies have shown a decrease in the regularity of locomotor-like activity in 
spinal cords with blocked V3 neurotransmission. In the same spinal cords, motor outputs were 
observed to become asymmetrical across the left and right half of the spinal cord. Additionally, 
blocking V3 IN signaling also demonstrated a change in the duration of stepping during walking, 
generating asymmetrical and variable walking rhythms. [4] This elucidates the importance of V3 
INs in establishing robust locomotion rhythm.  
V3 migration and distribution have also been reported. V3 INs in the lumbar spinal cord 
separate into dorsal and ventral (V3Ds and V3Vs, respectively) populations after migration. These 
spatially separated populations are electrophysiologically distinct and can be distinguished by 
four main attributes: f-I slope, Cm, first spike frequency, and sag amplitude at -120 mV [90]. 
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While some cells that were not spatially dorsal or ventral were found, the researchers were able 
to classify them based on these electrophysiological properties. Furthermore, these two 
populations were shown to be recruited differently during running or swimming in adult animals. 
Running recruited both populations while swimming tended to recruit V3Vs [90].  This 
difference was present throughout post-natal locomotion maturation. At P0, both V3 IN 
subpopulations exhibit different properties than their P21 counterparts but the two 
subpopulations were still electrophysiological distinct [91].  
While Sim1 is a marker for V3 INs, it is not required for V3 IN identity. In fact, V3 IN 
type (Uncx+ and VGluT2+) cells are present in Sim1 knockout mice. However, Sim1 plays an 
important role in migration and axon projection. Mice lacking Sim1 fail to display properly 
migrating V3 INs. Additionally, in Sim1 mutant mice, axons fail to extend as long as in control 
mice. [88]  
V3 INs are one of the least well characterized cell types in the ventral spinal cord. While 
some aspects of their functions are known, subtype markers and the factors involved in subtype 
maturation are unknown. However, their role in rhythm generation and burst regulation make 
them an important target for understanding CPGs. Furthermore, their commissural projections 
make them a potential cell type for reorganization around an injury site and functional recovery 
after spinal cord injury. This work contributes to that understanding by offering a way to obtain 
V3 INs without tedious dissection and purification of cells.  
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1.3.6 Ventral Spinal Populations and Motor Circuits 
Ventral spinal populations are a diverse population of neurons. While they have been 
broadly grouped into the aforementioned V0-V3 and MN populations, it should be evident that 
these methods of identification grossly understate the complexity of this system. Each population 
can be subdivided into more functionally specific categories.  The diversity of these cells results 
in the complex system of feedback and signaling that is used to control locomotion activity in 
vertebrates. While using developmental molecular markers are important for lineage tracing and 
neuronal subpopulation identification, this method of identification is not the end all be all for 
understanding IN function.  
The functional properties of ventral INs have some overlap and redundancy; silencing of 
a single population does not shut down all locomotion. While coordination has been shown to be 
decoupled (V0s) and robustness of rhythm disturbed (V3s), these populations are generally not 
the only INs involved in their respective aspect of locomotion.  In fact, the role of many IN 
populations may overlap (both V2a and V0s are involved in left-right alternation) while other 
INs function to fine-tune motion (V0Cs’ cholinergic input onto MNs).  Additionally, functionally 
specific populations may not arise from a single spinal population (e.g. not all IaINs are V1 in 
origin). All this taken together indicates a level of redundancy and attenuation in the overarching 
architecture of locomotion control.  
Another caveat for understanding ventral spinal populations is the widely used fictive 
locomotion assay for accessing ablation induced functional perturbations. These preparations 
utilize drug cocktails to activate and record spinal circuitry activity. It was found that in VGluT2 
mutant spinal cords, the drug cocktails were sufficient to induce “close-to-normal” patterns while 
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descending or ascending electric stimulation did not result in these patterns[92]. This surprising 
finding has direct implications for fictive locomotion assays that report more subtle changes in 
population ablated studies, suggesting that the chemical stimulation may bypass normal circuitry 
and directly affect recorded signals. This could also indicate that any IN population where drug 
cocktails were used could have a more severe phenotype than initially assumed[92].  
Finally, sensory input participates in CPG circuitry feedback. As seen in the location 
based sensory input of MNs, spatial order is vital for appropriate sensory input. Furthermore, 
IaIN and dorsal V3 IN populations both relay sensory input as part of their function. To better 
understand sensory input processing in the CPG circuitry, the specific signal sources and 
synaptic targets of dorsal V3 INs, IaINs, and any cells involved in sensory processing should be 
studied.  
 
1.3.7 Ventral Spinal Population Inductions from ESCs 
Cells of the central nervous system have been obtained through the differentiation of 
ESCs. Cell types include, but are not limited to, MNs [6], V2a INs [93], dopaminergic neurons 
[94], cerebellar neurons [95], cortical pyramidal neurons [96] , and even glia such as 
oligodendrocytes [97] and astrocytes [98].  
MN differentiation was first reported by Wichterle et al. By utilizing RA, Wichterle et al. 
was able to drive caudalization of the induced cells into a spinal identity [6,99]. Furthermore, the 
strong Shh signaling was able to drive Olig2 and later Hb9 expression. The derived cells 
functionally matured into cholinergic neurons [100]. To look at how altering RA and FGF 
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signaling effects rostral-caudal spinal identity, the same group used FGF in their media to target 
more caudal identities, which they verified with Hox gene expression [101].  The resulting MNs 
were transplanted into chick neural tubes and observed to settle within columns and to innervate 
appropriate muscle groups [101]. Furthermore, the MN differentiation protocol has been applied 
to human ESCs and iPSCs [102,103]. The time scale for MN induction in human cells were 
much longer than in mouse ESCs. However, it’s been shown that a combination of Shh agonists 
can expedite the MN induction process [104].  
Inductions have also been reported for other ventral spinal cell types. Brown et al 
reported the generation of V2a INs [15] from mESCs. Due to a large population of V2a INs in 
the brain stem and cervical spinal cord region, RA expression was dropped to 10 nM in the V2a 
induction [93,105]. Additionally, V2a relative location to MNs lead to SAG being replaced by a 
weaker Shh pathway agonist – purmorphamine[93]. Finally, to target the induction of V2as 
instead of V2bs, a notch inhibitor was used [93]. Additionally, V0 INs have been reported by  
Kim et al.’s induction of ~22% Evx1 expressing cell types by inducing with RA but not Shh 
signaling [106]. While there are many induction protocols to derive different CNS populations, 
many populations have not been covered. This dissertation provides a new method to derive a 
type of spinal interneurons not previously established.  
 
1.4 Genomic Engineering  
  Since the creation of the first knock-out mouse in 1989 genomic editing has been a vital 
tool for studying and understanding cell types and protein function in animal models. The 
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culturing of mESCs paved the way for the development of genetically engineered animals, most 
notably, knockout mice. In the late 1980s, Mario Capecchi, created the first knock-out mouse 
where cultured and genetically altered stem cells were introduced into mice embryos to generate 
a chimeric animal [107-109]. Chimeric animals are genetically mosaic, containing cells with two 
different genotypes, some of which would be in the reproductive organs. The chimeric animal 
would then be bred so that some of the genetically altered cells would give rise to gametes and 
ultimately result in animals that are heterozygous for a mutation. The heterogeneous animals 
would then be bred to generate heterozygous mutant animals. In knockout mice, mutations to 
both alleles of a specific gene enable researchers to study the effects of removing a gene in an 
animal [108]. Since their invention, knock-out mice have become a widely used and powerful 
tool to understand the role of specific genes within an organism. In addition to knock-out mice, 
reporter and lineage tracing mice have also been generated [110]. Reporter mice express a 
specific protein (e.g. green fluorescent protein) within a specific gene locus such that the protein 
would be present when the gene is being expressed. This allows or the study of the time course 
of gene expression. Lineage racing mice are used to look for cells that at any point had expressed 
a certain gene [111,112]. The most common lineage tracing mechanism uses the target gene 
locus to control Cre-recombinase expression. After the expression of the target gene, Cre-
recombinase would remove a stop sequence inserted before a ubiquitously expressed reporter 
protein so that the reporter protein would always be expressed [111,112]. Lineage tracing allows 
researchers to understand which cells at any given time expressed their gene of interest. These 
genetically engineered mice were vital for the identification and characterization of many 
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different cell populations, including V3 INs that are the focus of this thesis [4]. This section 
focuses on some of the history and current techniques for genomic editing.  
 
1.4.1 Homologous recombination and early gene engineering 
Genomic engineering has been sought after as early as the 1970s when Wigler et al. 
demonstrated that the herpes thymidine kinase gene could be transformed into mammalian cells 
[113]. Not long after, head-to-tail concatemers were observed in cells where DNA had been 
injected. The concatemers, a high copy number repetition in a single locus, revealed the 
homologous recombination mechanism in mammalian cells [114], which provided the basis for 
gene targeting in mice. Capecchi et al. demonstrated that two dysfunctional neomycin resistant 
gene could recombine to form a functional one [115]. Concurrently, Smithies et al. reported 
successful targeting of β-globin locus in cultured mammalian cells [116]. These demonstrations 
of editing and targeting a specific gene ultimately resulted in using ESCs to generate knock-out 
mice. Due to inefficiency of using electroporation to introduce a targeting vector, neomycin 
resistance was used as positive selection to isolate cells that had successfully incorporated the 
targeting vector [109]. Additionally, the occurrence of non-homologous recombination is about 
1000 fold higher than homologous recombination in any given experiment [117]. Thus, the TK 
gene was used as a negative selection group to help eliminate non-homologous 
recombination[108]. These practices were widely adopted to study genes in mice. Over 7,000 
genes’ in vivo functions have been reported by generating knockout mice, making homologous 
recombination a ubiquitous and influential technology [117]. There are even efforts to make a 
comprehensive mouse library for every protein-encoding gene [118].  
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Early genomic engineering work required PCR and enzyme based methods for 
amplifying and assembling long pieces of DNA [119]. These techniques were tedious and 
required a lot of verification to ensure a mutation-free PCR product. However, the use of 
artificial chromosomes for generating vectors via homologous recombination [120,121] and the 
advent of recombination technology, especially red-recombination, allowed large stretches of 
DNA to be incorporated into a backbone plasmid without the use of PCR [122,123]. This 
technology resulted in more efficient generation of targeting vectors for recombination. 
Unfortunately, the large homology arms were still unwieldy, necessitating better recombineering 
techniques.  
 
1.4.2 Engineering Nucleases for Genome Editing 
The use of genome targeting nucleases has greatly improved the efficacy of genomic 
engineering. Technology, such as clustered regulator interspaced sort palindromic repeats 
(CRISPR/CAS9), transcription activator-like effector nucleases (TALENs) and zinc finger 
nucleases (ZFNs) has been able to generate specific double stranded breaks in DNA which have 
provided a 50,000-fold increase in the probability of homologous recombination [124]. These 
highly customizable and versatile techniques have been shown to more efficiently generate 
knock-out and knock-in organisms. In fact, genome editing with nucleases was named the 
“Method of the Year 2011” by Nature Methods [125]. This section will discuss three of the most 
common nuclease targeting systems.  
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Zinc Finger Nucleases (ZFNs) 
First reported in 1996, ZFNs (Fig. 1.1A) are a modular combination of multiple DNA-
recognizing zinc finger proteins (ZFP) domains and the cleaving domain of endonuclease FokI 
[126].  The hybrid system allow for the creation of ZFNs that can bind to a wide variety of 
genetic targets. Each ZFN system is comprised of a set of heterodimer ZFN proteins; each with a 
set of ZFP to recognize a target and a cleavage domain to cut [127]. One ZFN monomer would 
bind upstream and the other would bind downstream of the cleavage site, with the Fok1 domains 
overlapping in the middle. This system takes advantage of the need for the FokI cleavage domain 
to dimerize prior to cleavage as the FokI cleavage domain cannot cut one side of a double strand 
by itself [128]. However, when both ZFN proteins recognize and bind to the correct targets, the 
cleavage domains can dimerize and cleave the DNA. 
The original ZFN design consisted of ZFP monomers recognizing a three base pair triplet. 
By fusing ZFP domains together, a longer and more specific sequence can be targeted for 
cleavage anywhere in a genome.  Unfortunately, not all ZFPs for DNA triplets have been 
identified. Of the known ZFPs, many have been characterized only by in vitro binding. This 
limitation greatly lowers the predictability of ZFPs in live systems [129]. 
 More recently, a method termed OPEN (oligomerized pool engineering) was reported. 
Using libraries of ZFP sequences, this method can identify combinations of ZFPs that can target 
9 bp site with 70-80% efficiency [130]. However, this method requires high expertise and intense 
labor, which makes it non-ideal for widespread use.  Another method for improving ZFP 
targeting is called CoDa (context-dependent assembly). This method uses previously established 
three ZFP arrays to target specific sites. By generating a library of N- and C- terminal ZFPs with 
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different centers, any N- and C- terminal ZFP can be joined if they share an identical middle ZFP. 
By accounting for the context of the adjacent ZFPs to design a desired ZF, this method can 
achieve comparable efficiency to OPEN while not requiring a comparable level of expertise or 
labor [131]. Despite improvements to designing de novo ZFNs, the efficiency is still not 100%. 
While ZFNs could be a very useful tool for cleaving DNA, affinity and specificity are problems 
that still must be addressed before widespread adoption. Furthermore, the design and assembly 
of ZFNs are still labor intensive and expensive which further limits the adoption of this method 
for genomic engineering[132].  
 
Transcription activator-like effector nucleases (TALENs) 
TALENs (Fig. 1.1B)also utilize the FokI endonuclease cleavage domain fused to a DNA 
binding domain. Instead of ZFPs, TALENs use TALEs (transcription activator-like effectors), 
which were originally isolated from pathogenic bacteria found in plants[133]. These TALEs are 
highly conserved amino acid sequence 33-35 in length [134]. The 12th and 13th residue of these 
repeat sequences are highly variable and function in DNA base recognition [134]. Understanding 
of this structure allowed for the engineering of TALE repeats to specifically bind to DNA 
sequences [135]. Currently the most common 12th and 13th variables for identifying guanine, 
adenine, cytosine, and thymine are, respectively, NN, NI, HD, and NG [135].  This simple 
mapping makes TALENS a more direct way to engineering specific nucleases than ZFPs.  
While TALENs have been shown to function in a wide variety of genomic editing 
applications, the construction of TALENs is not a trivial matter. The highly repetitious nature of 
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the sequences makes assembly fairly challenging. While resources are available to aid in this, the 
manual intensiveness hinders TALENs from being readily adopted for genomic engineering[132]. 
Figure 1.1 Simple schematics of nucleases for genomic editing. A) ZFNs with various ZFs 
represented by circles and connected to a FokI. Two ZFNs binding to different stretches of the 
genomic DNA enables FokI to dimerize and form a double-stranded break.  B) TALENS, like 
ZFNs, utilize the dimerization of FokI for DNA cleavage. Small rectangles represent TALEs that 
make up a complex TALEN DNA binding sequence. C) CRISPR/Cas9 system uses the guide 
RNA to specify the Cas9 protein’s binding and cleavage regions. 
  
Clustered regulator interspaced sort palindromic repeats (CRISPR/Cas9) 
CRISPRs (Fig. 1.1C) were first observed in bacteria and archaea in 1987[136] but their 
function as a bacterial immune system and evidence of adaptive CRISPR associated (Cas) 
related functions were not reported until 2007[137,138]. CRISPR provided immunity worked in 
three steps: insertion of invading DNA into the CRISPR array, generation of mature CRISPR 
RNAs from precursors, and the cleavage of foreign DNA by Cas proteins guided by the CRISPR 
RNAs [139]. While there are three types of CRISPR systems, only one requires a single Cas 
protein for guide RNA mediated cleavage [140]. The discovery of this single Cas protein, Cas9, 
as a double stranded break generator provided the basis for subsequent CRISPR/Cas9 system 
development.  
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Since its initial report in 2012, the CRISPR/Cas9 has been widely adopted due to its ease 
of use, efficiency, and versatility. In this system, to modify the DNA target site, one only needs 
to change the guide RNA sequence [141]. Furthermore, two mutations to the Cas9 protein were 
found that resulted in the Cas9 becoming a “nickase”, an enzyme that cut only one strand of 
DNA. When both mutations were introduced into the nuclease, Cas9 mutates into a DNA 
binding protein [140,141]. CRISPR/Cas9 system’s versatility lies in its ability to target multiple 
genes concurrently by introducing more than one guide RNA[142]. These possibilities have 
allowed CRISPR/Cas9 to have very broad uses in biology ranging from engineering cells to 
genetic studies. 
However, CRISPR/Cas9s also have off target effects. The Cas9 protein can interact with 
off-target DNA and the guide RNA tolerates multiple mismatches [143,144]. While dosage 
titration of the Cas9 protein and guide RNA could help minimize these off target effects [143], a 
newer method for improving Cas9 specificity is combining the mutant DNA binding Cas9 
protein with FokI monomer[145]. This new system couples the ease of Cas9/CRISPR 
manipulation with the improved specificity of a dimerizing system.  Still, better control of the 
nuclease systems muct be achieved before translation for human therapeutic uses.   
 
1.5 Concluding Remarks 
In this dissertation, I aimed to generate V3 INs from mESCs. Others’ work in 
understanding the developmental signaling pathways involved in ventral spinal specification as 
well as establishing MN/V2a induction protocols has provided a strong foundation and solid 
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starting point for this thesis. I considered the spatial and temporal expression patterns of different 
signaling molecules during development and accordingly altered previously differentiation 
protocols to yield the highest number of V3 INs. By doing so, I have established a novel 
induction protocol for generating V3 INs. Furthermore, to further purify V3 INs, I have 
developed a drug selectable cell line where a drug resistance gene is controlled by the post-
mitotic V3 marker, Sim1. This selectable cell line provides a high throughput and simple method 
for enriching the V3 IN population after induction. Finally, characterization of the selected cells 
allowed for verification of V3 INs’ identity and function. In this thesis, I present the results from 
these two aims.  
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Chapter 2: Directed Differentiation of V3 
Interneurons from Mouse Embryonic Stem 
Cells1 
 
2.1 Introduction 
V3 interneurons (INs) are commissural glutamatergic neurons that have been shown to be 
involved in rhythm generation networks within the spinal cord known as central pattern 
generators (CPGs) [4,90,92].  They can be identified by the p3 progenitor domain markers, 
Nkx2.2 and Ngn3 and the post-mitotic IN marker, Sim1 [36,89].  More recently Uncx has been 
                                                 
1 This work is published in Xu H and Sakiyama-Elbert S. (In Press) The Directed Differentiation of Spinal V3 
Interneurons from Mouse Embryonic Stem Cells. Stem Cells and Deveolopment. PMID: 26165862and is reprinted 
with permission of the publisher 
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shown to be a mature V3 marker [88,146]. Initial fictive locomotor assays in Sim1 knockout 
mice suggest that V3 INs have a role in balancing locomotor outputs in the spinal cord to 
regulate left-right alternation in gait [4]. More recent studies have demonstrated that spatially 
separated and functionally distinct subpopulations of V3 INs (termed V3ds and V3vs) can be 
differentially recruited for running and/or swimming [90]. V3 INs also have the ability to cross 
the midline and synapse onto motoneurons (MNs) and other INs across multiple spinal segments 
[36]. These findings suggest that V3 INs play a critical role in locomotor coordination and may 
be involved in local reorganization after spinal cord injury (SCI).  An efficient method to obtain 
V3 INs is necessary for enhanced understanding of CPGs and recovery after SCI.  
ESCs can provide a plentiful cell source for cell replacement therapies and to study 
developmental biology.  Protocols using RA and sonic hedgehog (Shh) signaling to direct 
differentiation of ESCs into various ventral spinal cell identities including MNs [6] and V2a INs 
[93] by mimicking conditions found in the developing ventral neural tube have been reported.  
During development, RA released from laterally positioned somites [147,148] and Shh released 
from the notochord and floor plate generate overlapping gradients on the neural tube [6,39-41].  
Shh diffuses dorsally from the floor plate and notochord, generating a ventral to dorsal signaling 
gradient (Fig. 2.1A).   RA is a caudalizing factor in neuronal differentiation [99,106,147,148]  
(Fig. 2.1D) and may help pattern the dorsal-ventral identity of embryoid body (EB)-derived 
neuronal populations in vitro [148].  These two overlapping gradients specify different 
progenitor domains (pMN and p0-p3) within the ventral cord, which give rise to MNs and 
ventral IN classes (V0-V3), and are identified by distinct transcription factors [36,37,39,149-
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152]. This complex interplay between Shh and RA serves as a basis for specifying ventral neural 
differentiation from ESCs.  
 
 
 
Figure 2.1  (A) Diagram depicting the ventral developing neural tube.  The gradient of Shh 
arising from the floorplate (FP) establishes the ventral progenitor domains (p1-3 and pMN).  
Specific transcription factors expressed in these domains drive the maturation of the committed 
domains (V1-V3 and MN), which are defined by specific transcription factors (shown on the far 
right).  Adapted from Brown, et al.[39,93].  (B) A schematic depicting the effect of time and 
concentration on establishing progenitor domains.  With increasing duration of high Shh 
exposure, more ventral domains are established.  Adapted from Dessaud, et al. [37].  (C) 
Schematic depicting the distance from RA-expressing somites. (D) Illustration of the rostral-
caudal axis and direction of increasing RA expression. 
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In this study, we establish a novel protocol to generate V3 INs from ESCs by assessing 
the effects of increasing Shh signaling, prolonging the duration of Shh exposure, and decreasing 
RA concentration on p3 progenitor and post-mitotic V3 IN marker expression in ESC-derived 
neural cultures. V2a INs, which lie dorsal to MNs, require a weaker Shh signaling agonist than 
do MNs.  Since V3 INs lie ventral to both V2s and MNs [38,39], we hypothesized that further 
increasing the Shh signaling level would promote increased differentiation of V3 INs.  Previous 
studies suggested that a more ventral spinal fate is specified by increasing the duration of Shh 
exposure, therefore we also chose to study the effects of varying the duration of Shh exposure of 
cell fate (Fig. 2.1B) [37,38,151]. Furthermore, because the progenitor p3 domain lies further 
from the RA-releasing somites than the pMNs, we hypothesized that a lower RA concentration 
could further improve V3 IN induction.  Cells obtained with our protocol can be used for 
studying CPG connectivity and cell-based transplantation therapies.   
 
2.2 Materials and Methods 
2.2.1 Culture of ESCs  
RW4 mouse ESCs (American Type Culture Collection, Manassas, VA) were cultured on 
T-25 flasks coated in 0.1% gelatin (Sigma, St. Louis, MO).  Cells were cultured in complete 
media consisting of Dulbecco’s Modified Eagle Medium (DMEM 11965, Life Technologies, 
Carlsbad, CA) containing 10% newborn calf serum, 10% fetal bovine serum, and a 1:100 
dilution of a 100x nucleosides mix (EMD Millipore, Bellerica, MA).  Cells were routinely 
passaged every other day by washing with DMEM 11965 containing 25 mM HEPES (Life 
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Technologies) and dissociating with 1 mL 0.25% trypsin ethylene diamine tetra acetic acid 
(EDTA, Life Technologies), quenching with 4 mL complete media, and plating 1 mL into a new 
T-25 gelatin coated flask containing a final volume of 5 mL media with 1000U/mL leukemia 
inhibitory factor (EMD Millipore) and 100 µM β-mercaptoethanol (Life Technologies). 
 
2.2.2 Formation and induction of EBs 
RW4 ESCs were aggregated to form EBs on a non-adhesive agar-coated surface and 
induced to generate neural progenitors using our previously established 6 day induction protocol 
(2-/4+ )[6,99,153] or an 8 day induction protocol (2-/6+).  Cells were cultured in suspension for 
two days on 100 mm petri dishes pre-coated with 0.1% agar (Thermo Fisher Scientific, Waltham, 
MA) in DFK-5 media comprised of 1:1 DMEM/F12 (Life Technologies) with 5% knockout 
serum replacement (Life Technologies), 1x insulin transferrin selenium (Life Technologies), 100 
μM β-mercaptoethanol, 50 μM nonessential amino acids (Life Technologies), and a 1:200 
dilution of a 100x nucleosides mix.  During the first two days, the cells are not exposed to RA or 
SAG (hence 2-), allowing the cells to aggregate into multi-cellular EBs.  After the first two days 
of aggregation, EBs were plated on gelatin.  200 μL of EBs were removed from the 100 mm 
plate and replated onto one well of a gelatinized six well plate.  DFK-5 media was added to a 
final volume of 2 mL and supplemented with RA (Sigma) (0 μM to 10 μM) and SAG (EMD 
Millipore) (0 μM to 1.25 μM) on day 3 through the end of the induction (either 4 days or 6 more 
days for 4+ or 6+, respectively).  Media with RA and SAG was replaced every two days for four 
(2-/4+) or six (2-/6+) days (Fig. 2.2A).   
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2.2.3 Quantitative real-time PCR  
Following induction, each well of a six well plate was lysed with 750 μL of buffer RLT 
from the RNeasy Mini Kit (Qiagen, Valencia, CA).  RNA was extracted per the manufacturer’s 
instructions.  High Capacity RNA-to-cDNA Kit (Life Technologies) generated cDNA from 
extracted RNA.  TaqMan Gene Expression Assays (Life Technologies; Table 2.1) and TaqMan 
Fast Advanced Master Mix (Life Technologies) were subsequently combined with the purified 
cDNA for qRT-PCR.  Reactions were then performed using a Step One Plus Applied Biosystems 
thermocycler with the default protocol: 95°C for 20s, 40 cycles of 95°C for 1s and 60°C for 20s.  
Ct values, the number of cycles necessary for the fluorescent intensity to increase exponentially, 
were recorded and normalized to β-actin expression.  The comparative ΔCt method [154] was 
used to analyze the mRNA expression levels in cultures post induction (2-/4+ and 2-/6+).  Fold 
differences in relative mRNA expression levels over the control cultures are reported for each 
gene (n ≥ 3 for all groups). 
Table 2.1: TaqMan Gene Expression Assays for qRT-PCR 
Marker Life Tech Identification 
Beta-Actin Mm00607939_S1 
Sim1 Mm00441390_m1 
Nkx2.2 Mm00839794_m1 
HB9 Mm00658300_G1 
RAX Mm01258704_m1 
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2.2.4 Live/Dead Viability assay 
Live/Dead reagent (Life Technologies) consisting of calcien-AM and ethidium 
homodimer was used to visualize live and dead cells, respectively. Cells were dissociated and 
incubated in Live/Dead reagents as per manufacturer instructions for flow cytometry. For each 
culture, 30,000 events were recorded using a BD LSRII flow cytometer (Becton Dickinson, 
Franklin Lakes, NJ).  Data analysis was performed using FloJo software (FloJo, Ashland, OR). 
 
2.2.5 Dissociation and plating of EBs 
Standard tissue culture plates were pre-coated with 0.01% poly(ornithine) solution 
(Sigma) at 37°C for 1 hour. Poly(ornithine) was removed and plates were washed with a HEPES 
buffered saline solution 3 times. Plates were then coated with 0.01 mg/mL laminin (Life 
Technologies) in HEPES buffered saline solution overnight and washed 3 times before use as 
laminin coated plates. Induced 2−/6+ EBs were allowed to settle and supernatant was collected. 
Then 0.25% Trypsin-EDTA was used to dissociate the EBs. Dissociated cells were plated at a 
density of 100,000 cells/cm2 in the collected DFK-5 supernatant. 
 
2.2.6 Immunocytochemistry 
For plated cultures, cells were fixed by adding 4% PFA in PBS to the cultures for 20 
minutes at room temperature, permeabilized with 0.01% Triton X-100 (Sigma) for 20 minutes.  
Cells were then blocked with 5% normal goat serum (Sigma) in PBS for 1 hour and stained 
overnight in 2% normal goat serum in PBS with added primary antibody (mouse anti-Nkx2.2, 
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1:100,  Developmental Studies Hybridoma Bank; mouse anti-Ngn3, 1:100, Developmental 
Studies Hybridoma bank; mouse anti-Uncx, 1:500, EMD Millipore) overnight at 4ºC.  Cells were 
then stained for 1 hour in 2% normal goat serum in PBS with Alexa Fluor conjugated antibodies 
(goat anti-mouse IgG 488 Life Technologies) at 4º C, then Hoechst 33258 (1: 1000, Life 
Technologies) for 15 minutes at room temperature, and stored in PBS at 4ºC.  
 
2.2.7 Probe synthesis for in situ hybridization 
Plasmids for in situ hybridization probes were a generous gift from Dr. Paul Gray 
(Washington University) [155].  Gene fragments from verified plasmids were linearized by 
direct PCR amplification using ReadyMade Primers (SP6 Promoter and T7 Promoter, Integrated 
DNA Technologies, Coralville, IA).  Digoxigenin (DIG)-labeled antisense and sense RNA 
probes were made using PCR products as template and T7 RNA polymerases (Roche, 
Indianapolis, IN).  Probes were used at a concentration of 1–2 μg/ml.  Sense counterparts of all 
probes were tested to ensure probe specificity. 
 
2.2.8 In situ hybridization 
Cell cultures were fixed and stained with modifications protocol from previously 
described [155-157].  Cell cultures were fixed in 4% paraformaldehyde (PFA) for 10 minutes 
and washed 3 times in diethylpyrocarbonate (DEPC, Sigma) treated PBS at room temperature. 
Next, cells were treated with RIPA buffer (150 mM NaCl (Thermo Fisher Scientific), 1% NP-40 
(Thermo Fisher Scientific), 0.5% Na deoxycholate (Thermo Fisher Scientific), 0.1% Sodium 
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dodecyl sulfate (Sigma), 1 mM EDTA (Thermo Fisher Scientific), 50 mM Tris in 
diethylpyrocarbonate (Sigma) treated water at pH 8.0) and washed for twice with DEPC treated 
PBS. Then the cells were incubated in 0.1 M triethanolamine-HCl (1.3% triethanol amine (Sigma) 
and 0.4% HCl (Thermo Fisher Scientific)) with 0.25% acetic anhydride (Sigma) for 10 minutes. 
Cells were washed in 1x sodium citrate buffer for 5 minutes at room temperature. 3 additional 
washes with DEPC treated PBS were performed before cells were blocked in hybridization 
buffer (50% formaldehyde (Sigma), 5x sodium citrate buffer (SSC, Life Technologies), 0.3 
mg/mL yeast RNA (Sigma), 0.1 mg/mL heparin (Sigma), 1x Denhardt’s solution (Life 
Technologies), 0.1% tween (Sigma) and 5 mM EDTA) for 4-6 hours at room temperature.  Cells 
were incubated in hybridization buffer containing 1–2 μg/ml DIG-labeled antisense cRNA 
overnight at 65°C. Probed cells were washed in twice in 0.2× SSC at 62°C, and incubated in 
0.2× SSC for 60 minutes at 65°C.  Washed cells were adjusted to room temperature and blocked 
with 10% deactivated horse serum (Life Technologies) in phosphate buffered saline with 2 
mg/mL bovine serum albumin and 0.1% Triton X-100 (PBT), and incubated in alkaline 
phosphatase-labeled anti-DIG antibody (1:2000 in 10% deactivated horse serum in PBT; Roche) 
overnight. Cells were further washed with PBT and color was visualized using nitro blue 
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Roche).  Staining was stopped with 4% 
PFA after visual inspection. Cell nuclei were stained with the DNA binding dye Hoechst (1:1000, 
Life Technologies) and by immunocytochemistry with Nkx2.2.  
 
2.2.9 Flow cytometry 
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Immediately following the induction protocol, EBs were stained for flow cytometry.  
Cultures were dissociated with 0.25% trypsin-EDTA for 20 min at 37°C.  An excess volume of 
complete media was added to quench the trypsin-EDTA, and cultures were triturated to obtain 
single cell suspensions.  Cells were centrifuged at 360xg for 6 minutes, the media was removed, 
and the cells were fixed, permeabilized, and stained according to the Transcription Factor Buffer 
Set (BD Pharmingen 562725, Franklin Lakes, NJ) manufacturer’s instructions with mouse anti-
Nkx2.2 (1:100), mouse anti-Isl1 (1:100; Developmental Studies Hybridoma Bank), and mouse 
anti-Hb9 (1:20; Developmental Studies Hybridoma Bank) primary antibodies and appropriate 
Alexa Fluor secondary antibodies (1:200, Life Technologies).  Following the induction protocol, 
nuclei were stained with Hoechst (0.5 μg/ml, Life Technologies) for 15 min.  For each culture, 
10,000 events were recorded using a Canto II flow cytometer (Becton Dickinson, Franklin Lakes, 
NJ).  Data analysis was performed using FloJo software (FloJo, Ashland, OR).  Debris was 
removed by gating using the forward scatter versus side scatter and Hoechst fluorescence versus 
forward scatter plots.  Control groups of cells stained with only secondary antibodies were used 
to determine gating parameters.  Results of the flow cytometry are presented as percentage 
primary antibody+ cells out of the total Hoechst+ population.  Sample gating is presented in Fig 
2.5.  
 
2.2.10 Statistics 
For quantitative experiments, at least 3 replicates of each condition were analyzed.  For 
cell counting, at least 3 images were analyzed of every replicate to provide a representative 
sample of the replicate. Statistica software (version 5.5, StatSoft, Inc., Tulsa, OK) was used for 
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statistical analysis.  Significance was determined using Scheffe’s post hoc test for analysis of 
variance with 95% confidence.  Average values are reported with error bars indicating the 
standard error of the mean.   
 
2.3 Results 
2.3.1 Effect of SAG concentration and duration of exposure on gene 
expression 
The effect of increasing the concentration and duration of exposure of SAG on gene 
expression was examined using qRT-PCR to evaluate expression of V3 and pMN ventral neural 
markers (Sim1, Nkx2.2, and Hb9).  Concentrations of SAG were varied from 0.5 to 1.25 µM 
with 2 µM RA present, and samples were collected after 2-/4+ and 2-/6+ inductions.  In this 
notation, “2-” refers to the number of days ES cells are allowed to aggregate into EBs without (-) 
RA and SAG (middle section of Fig. 2.2A). The “4+” or “6+” refers to the number of days the 
EBs are exposed to (+) RA and SAG (right section of Fig. 2.2A).  mRNA expression fold change 
was determined by comparing qRT-PCR Ct values of induced cells to uninduced cells that were 
not exposed to RA or SAG over the same culture period (n ≥3 for all conditions).  Expression of 
the post-mitotic V3 marker, Sim1, increased across all concentrations of SAG when the SAG 
exposure time increased from 4 to 6 days (2-/4+ to a 2-/6+ induction) (Fig. 2.2B).  After the 2-/6+ 
induction, the group treated with 0.5 µM SAG exhibited significantly higher levels of Sim1 
expression than the group treated with 1 µM SAG (22.5 ± 0.5 fold greater versus 15.0 ± 1.3 fold 
greater than uninduced control).  Further reduction of the SAG concentration to as low as 0.05  
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Figure 2.2.  Effect of SAG concentration and duration of exposure on gene expression.  (A) 
Schematic depicting the 2-/6+ induction protocol where ESCs are aggregated in agar coated plates 
for 2 days and then exposed to 6 days of RA and Shh signaling.  (B, D, E ) qRT-PCR results 
(n=3) at the end of a 2-/4+ and 2-/6+ induction for mRNA levels compared to the uninduced (no 
RA, no SAG) control.  (B) Sim1 gene expression after induction. All 2-/6+ groups express 
significantly more Sim1 than their 2-/4+ counterparts.  0.5 µM SAG at 2-/6+ was significantly 
greater than 1 µM and 1.25 µM groups.  * denotes p < 0.05 versus the same SAG concentration 
with the 2-/4+ induction; # denotes  p < 0.05 versus 1 µM SAG group at the same time point.  (C) 
The effect of SAG concentration on cell death. # denotes p < 0.05 versus 1 µM SAG. ¤ denotes p 
< 0.05 versus 1.25 µM SAG. (D) Nkx2.2 gene expression after induction. At 0.5 µM SAG, 
Nkx2.2 expression at 2-/6+ was significantly greater than at 0.75 µM, 1 µM, and 1.25 µM.  ^ 
denotes p < 0.05 versus 0.75 µM, 1 µM, and 1.25 µM at the same time point (2-/6+).  (E) Hb9 
expression after induction. No significance was observed across SAG concentration groups for 
Hb9 at either time points. * denotes p < 0.05 versus 2-/4+ induction groups at the same SAG 
concentration.   
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µM did not alter Sim1 expression significantly. Additionally, after the 2-/6+ induction, the group 
treated with 0.5 µM SAG exhibited significantly higher levels of Nkx2.2 mRNA (30.5 ± 4.4 fold 
greater than uninduced control) compared to other SAG concentrations tested (Fig. 2.2C). 
Furthermore, Hb9 expression did not change significantly with SAG concentration at a given 
time point, but it was lower for the 2-/6+ induction compared to the 2-/4+ induction in most 
groups (Fig. 2.2D). Hb9 and Nkx2.2 expression levels showed similar trends to the Sim1 results, 
indicating that prolonged exposure promotes the targeted gene expression for V3 INs. We 
observed, at higher SAG concentrations, more EBs detached in cultures on gelatin-coated plates. 
To understand why we were observing a decrease in Sim1 induction efficiency, we assessed the 
percentage of cells surviving after the 2-/6+ induction with 0.5, 0.75, 1.0, and 1.25 µM SAG.  We 
found that there was a significant increase in cell death at 1.25 and 1.0 µM SAG (Fig. 2.2C). 
Therefore, 0.5 µM SAG and the 2-/6+ induction protocol were used for subsequent studies.   
 
2.3.2 Effect of RA concentration on gene expression 
To investigate the effect of RA concentration on ventral neural identity, qRT-PCR was 
used to evaluate changes in Sim1, Nkx2.2, and Hb9 expression.  The concentration of RA was 
varied from 0.005 to 10 µM in combination with SAG (at a constant level of 0.5 µM), and 
samples were collected at the end of the 2-/6+ induction protocol. Gene expression levels were 
compared to baseline concentration for the motor neuron induction protocol (2 µM RA), mRNA 
expression fold change was established by comparing qRT-PCR Ct values of all induced groups 
to the group treated with 2 µM RA and 0.5 µM SAG (n ≥ 3 for all conditions, highest Nkx2.2 
and Sim1 levels in Fig. 2.2).  When RA concentration decreased to 0.01 µM, Sim1 expression  
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Figure 2.3.  The effect of RA concentration on ventral neural marker gene expression.  (A) Sim 
1 and Nkx 2.2 expression after inudction compared to 0.5 µM SAG and 2 µM RA.  * denotes p < 
0.05  versus 0.1 µM and 10 µM RA groups.  Dotted line denotes upregulation threshold 
compared to 0.5 µM SAG and 2 µM RA.  (B) Hb9 expression after induction compared to 0.5 
µM SAG and 2 µM RA.  *** denotes p < 0.001 versus all other groups.  ** denotes p < 0.01 
versus 0.0005 µM and 0.001 µM RA groups.  # denotes p < 0.05 versus 0.0005 µM RA group. 
Dashed line denotes downregulation threshold compared to 0.5 µM SAG and 2 µM RA. (C) 
RAX expression after 2-/6+ induction compared to 0 µM SAG and 0 nM RA.  ^ denotes p < 0.05 
versus 0 nM RA  group.  Dashed line denotes downregulation threshold compared to uninduced 
control. 
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was found to increase 11.4 ± 2.9 fold versus the 2 µM RA group (Fig. 2.3A).  Similarly, 
decreasing RA concentration to 0.01 µM significantly increased Nkx2.2 mRNA levels (4.3 ± 0.4 
fold) versus the 2 µM RA group.  Hb9 expression levels decreased significantly when the RA 
concentration was lowered for all concentrations tested compared to the 2 µM RA group (Fig. 
2.3B).  Further lowering of RA concentration beyond 0.01 µM did not significantly change Sim1 
or Nkx2.2 expression levels. The increase in Sim1 and Nkx2.2 combined with the decrease in 
Hb9 matched gene expression patterns expected for V3 INs, indicating lowering the 
concentration of RA did induce further ventralization of our culture. 
To test for unwanted rostralization with lower RA levels, gene expression levels of retina 
and anterior neural fold homeobox (RAX, a hypothalamus marker) were examined using qRT-
PCR. We tested the effect of varying the RA concentration from 0 to 10 µM with 0.5 µM SAG 
using a 2-/6+ induction protocol. All data were compared to the uninduced condition at the same 
time point to investigate the extent of rostralization for each RA concentration.  All conditions 
showed decreased RAX expression compared to uninduced controls (Fig. 2.3C, dashed line).  
Additionally, RAX expression was significantly lower for groups at 0.01 µM RA and 0.1 µM 
RA compared to the groups at 0 µM RA and 0.5 µM SAG.  The down regulation of RAX 
suggests that Sim1 expression was not an indicator of hypothalamus induction in these cultures. 
 
2.3.3 Immunocytochemistry and flow cytometry  
To confirm the results observed by qRT-PCR, immunocytochemistry and flow cytometry 
were used to assess transcription factor expression at the protein level.  Nkx2.2 immuno-  
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Figure 2.4.  The effect of decreasing RA concentration on Nkx2.2 expression by 
immunocytochemistry.  EBs fixed at the end of 2-/6+ induction with 0.5 µM SAG and 2 µM RA 
(A-C), 0.1 µM RA (D-F), 0.01 µM RA (G-I).  Hoechst nuclear staining (A,D,G), Nkx2.2 
antibody staining (B, E, H), and overlay of the two stains (C, F, I) are shown.  (J) Quantification 
of p3 (Nkx2.2 and Ngn3) and V3 (Uncx) marker immunocytochemistry on dissociated EBs 
plated onto laminin-coated plates. Values given as % cells positive for marker. * denotes 
significance (p < 0.05) compared to 2 µM RA. ^ denotes significance (p < 0.05) compared to 0.1 
µM  RA and 2 µM RA. Scale bar = 50 µm. 
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Figure 2.5. The effects of RA concentration on neuronal marker expression by flow cytometry.  
Flow cytometry performed on induced EBs after the 2-/6+ induction with 0.5 µM SAG and 
varying RA concentrations (0.01, 0.1 and 2 µM) .   (A) Sample gating of flow cytometry for 2 
µM RA and 10 nM RA for negative control (secondary antibody only, -ctrl), Nkx2.2, Hb9, and 
Isl1 stains. Region on left is negative while region on right is positive.  (B) Quantification of 
percentage cells staining positive for Nkx2.2, Hb9, and Isl1 across various RA concentrations.  * 
denotes significance (p < 0.05) versus compared to 2 µM RA groups.  
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cytochemistry on intact EBs (Fig. 2.4 A-I) qualitatively suggested an increase in Nkx2.2 mRNA 
levels with decreasing RA.  To quantify this difference, immunocytochemistry was performed on 
dissociated EBs to see if p3 and V3 marker expression was increased in induced cultures.  Total 
cell nuclei and nuclei positive for the markers were counted and the percentage of cells positive 
for the following markers: Nkx2.2, Ngn3, and Uncx was calculated.  For all three markers, the 
percentage of cells positive for the given marker increased when RA concentration was 
decreased from 2.0 to 0.01 µM RA.  Nkx2.2+ cells increased from 9% to 18%, Uncx+ cells 
increased from 1% to 8%, and Ngn3+ cells increased from 7% to 13% (Fig. 2.4J).  Similarly, 
flow cytometry showed the percentage of Nkx2.2+ cells increased with decreasing RA 
concentration down to 0.01 µM RA (Fig. 2.5). Groups induced with 0.01 µM RA (and 0.5 µM 
SAG) using the 2-/6+ induction protocol generated significantly more Nkx2.2+ cells than those 
induced with 2 µM RA (and 0.5 µM SAG) (Fig. 2.5C).  The percentage of cells positive for MN 
marker Isl1 also decreased significantly at 0.01 µM RA compared to 2 µM RA (Fig. 2.5D). The 
percentage of Hb9+ cells decreased significantly at both 0.01 µM RA and 0.1 µM RA compared 
to 2 µM RA, similar to the low Hb9 mRNA levels seen in Fig. 2.3B. The decrease in MN marker 
expression and increase in p3 marker expression corroborated that lowering RA further 
ventralized the induced neural population.   
 
2.3.4 In situ hybridization of Sim1 on EBs  
Due to the lack of a specific Sim1 antibody, in situ hybridization was used to confirm the 
presence of Sim1+ cells. EBs were dissociated after 2-/6+ induction (varying RA from 0.01 µM to 
2 µM and constant 0.5 µM SAG). Performing in situ hybridization for Sim1 showed that  
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Figure 2.6.  Sim1 and Nkx2.2 in dissociated EBs indicated by in situ hybridization and 
immunocytochemistry.  Cultures induced with the 2-/6+ protocol with 0.5 µM SAG and 2 µM 
RA (A-D), 0.1 µM RA (E-H), 0.01 µM RA (I-L) were dissociated and plated and then stained by 
in situ hybridization for Sim1 and immunocytochemistry for Nkx2.2 .  Sim1 in situ hybridization 
(A, E, I), Nkx2.2 antibody staining (B, F, J), Hoechst nuclear stianing (C, G, K) and overlay of 
all three stains with Nkx2.2 false colored as red and Hoechst false colored as greeen (D, H, L) 
are shown.  (M) Quantification of Scale bar =  50 µm. 
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lowering the RA concentration resulted in an increase in Sim1+ cells.  At 0.01 µM RA, more 
Sim1+ cells were observed than at 0.1µM and 2µM RA (Fig. 2.6 M). When dissociated EBs were 
stained with Nkx2.2 antibody after in situ hybridization, Nkx2.2 and Sim1 expression was 
observed to co-localize (Fig. 2.6 I-L, arrows).  This observation suggested that the induced cells 
are spinal V3 INs. 
 
2.4 Discussion 
Commissural glutamatergic V3 INs have been shown to be involved in rhythm regulation 
in the CPGs [92,158] by helping regulate left-right walking gait and generating robust rhythmic 
bursting [4,90].  Their role in regulating CPGs makes V3 INs an interesting target for 
understanding the development of the locomotor pathway and local rewiring after SCI.  However, 
a readily available cell source for isolation of V3 INs in culture would allow greater 
understanding of their role at a cellular level.  In this paper we present data on establishing a 
novel induction protocol for generating V3 INs from mouse ESCs.   
Using a previously established 2-/4+ protocol for the induction of MNs from mouse ESCs 
as a starting point, we explored the effects of varying level and duration of exposure to Shh 
signaling on p3 and V3 marker expression [6].  Although we hypothesized that increasing both 
the magnitude and duration of Shh exposure would drive more ventral neural identities, qRT-
PCR data indicated that increasing the duration rather than the concentration of Shh signaling 
agonist appeared to be more effective for induction of V3 INs.  While the expectation that lower 
Shh exposure will result in more dorsal cell types has proven true for V2a and V0 differentiation, 
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it has been observed in our lab that higher concentrations of SAG do not improve MN induction 
and appear to have a negative effect on EB health. The decreased efficacy of SAG at 
concentrations higher than 1 µM has been reported at early time points (30 hrs) [29]. Gli, a 
downstream target of SAG, was coupled to a luciferase assay and luciferase activity was reported 
to peak between 0.1 µM and 1 µM SAG, indicating peak SAG-driven Gli activation occurs 
somewhere between these values [29].  We surmised the observed decrease in Sim1 expression 
in our studies at concentrations of 1 µM or greater could be due to toxic effects of high SAG 
levels.  This was confirmed with live-dead quantification of our induced cultures (Fig. 2.2C).  
Since SAG efficacy was limited at higher concentrations, an increase in Sim1 expression levels 
was only observed with increasing SAG exposure time and not concentration. 
 Because V3 INs are further than MNs from RA-releasing somites along the neural 
tube [147], we hypothesized that lowering the RA concentration would increase V3 IN 
differentiation.  Our qRT-PCR data showed that decreasing RA concentration not only increased 
Nkx2.2 and Sim1 gene expression but also decreased Hb9 expression, indicated that lowering 
RA allows differentiation of more ventral populations.  This data was further supported by flow 
cytometry and immunocytochemistry for Nkx2.2 and Isl1, as well as in situ hybridization for 
Sim1. Others have also shown that lowering RA to the 0.001-0.01 µM range increases Nkx2.2 
expression [148], which matches with our observations.  
While we observed increases in Sim1 expression by qRT-PCR, validation of the 
induction protocol required the presence of cells with high levels of Sim1 expression. Since a 
specific Sim1 antibody is not available, we used in situ hybridization to confirm that the increase 
in overall Sim1 expression, as seen in qRT-PCR, can be attributed to some cells with high levels 
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of Sim1 expression and not low levels of Sim1 expression in most cells.  When dissociated EBs 
were stained with Nkx2.2 antibody after in situ hybridization, Nkx2.2 and Sim1 expression was 
observed to co-localize (Fig. 2.6 I-L, arrows).  This observation suggested that the induced cells 
are spinal V3 INs.  
Because Sim1 is not uniquely expressed in V3 INs, it was necessary to ensure that the 
induction protocol did not give rise to other Sim1+ neural populations.  One concern with 
decreasing RA concentration is potential rostralization of the resulting cells.  Since Sim1 is also 
expressed in the hypothalamus [159], we wanted to ensure the cells we obtained were not 
hypothalamus cells.  To this end, the level of gene expression of the hypothalamus marker RAX 
was measured in the Sim1+ cultures generated in the low RA, high SAG induction protocol.  Due 
to the heterogeneity of induction protocols [6,106,148], if the induced Sim1+ EBs upregulate 
RAX, then they could have hypothalamic identity [160-162].  The drastic downregulation of 
RAX after induction (Fig. 2.5) suggests that the Sim1+ cells observed in the induced culture are 
not hypothalamic in nature.  One caveat worth noting is that qRT-PCR experiments report 
population averaged data. Fold changes of mRNA expression levels are reflective of an average 
value across the whole experimental population in comparison to a control population. A large 
increase in expression level in qRT-PCR could represent a large increase in a few cells or a small 
increase in many cells. While we see a decrease in RAX expression across the whole population, 
the existence of a rare RAX+ cell cannot be ruled out. Unfortunately, a reliable antibody for RAX 
does not exist and thus population averaged experiments are the most direct way to quantify the 
extent of RAX expression. 
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This study establishes a novel induction protocol for inducing V3 INs from mouse ESCs 
by demonstrating successful differentiation of Sim1+, non-hypothalamic cells in cultures that 
also express the p3 progenitor marker Nkx2.2.  A scarce population of V3 INs exists in the 
developing spinal cord, totaling ~10% of the four ventral spinal cell types, making dissection 
tedious and expensive.  The duration and potentially scalable nature of this protocol make our 
method an easier, cheaper, and faster way to obtain V3 INs than dissection. Based on the Uncx 
and Sim1 staining, about 8% of the induced cells are V3 INs. One 100 mm Petri-dish of induced 
2-/6+ EBs has about 21 million cells. This means about 1.6 million V3 INs can be obtained from 
one induction culture on this small bench scale, which would generally be sufficient for a rodent 
transplantation study. This work paves the way for future transgenic drug-selectable or lineage 
tracing cell lines to better understand the role of V3 INs in the spinal cord. Additionally, this 
protocol for V3 IN induction could potentially be adapted for human ESCs or induced 
pluripotent stem cells, much as the MN differentiation protocols from mouse ESCs have been 
adapted for these human cell types [163,164].  This method to generate Sim1+ cells can serve as 
a cell source for future studies exploring the role of V3 INs in CPGs and SCI therapy.
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: A Puromycin Selectable Cell Line 
for the Enrichment of Mouse Embryonic 
Stem Cell Derived V3 Interneurons 
3.1 Introduction 
Pluripotent stem cells have the potential to be a plentiful cell source for many different 
cell types. Differentiation protocols have been established to generate specific cell types from 
embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). In the central nervous 
system, differentiation protocols for ESCs have been developed for several populations, 
including midbrain and hindbrain dopaminergic and serotonergic neurons [94,165], spinal 
motoneurons (MNs) [6,99], and V0, V2a, and V3 spinal interneurons (INs) [93,106,166]. These 
populations (MNs and INs) contribute to locomotion either by directly innervating muscle or by 
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playing a role in central pattern generator (CPG) circuitry [4,36,48,49,92]. By deriving ventral 
spinal populations from ESCs or iPSCs, we can better study these populations in culture and 
their role in locomotion and reorganization after spinal cord injury.  
One ventral spinal population that may contribute to reorganization after spinal cord 
injury is the commissural, glutamatergic V3 IN population. V3 INs arise from the Nkx2.2+ p3 
progenitor domain and express the transcription factor Sim1 upon reaching the post-mitotic stage 
[89]. They contribute to rhythm generation networks within the spinal cord by playing a role in 
regulating left-right alternation of gait and in balancing locomotor outputs [4,90]. This 
population has been shown to cross multiple spinal segments and synapse onto MNs and other 
INs [4,90]. During maturation, V3 INs separate spatially during post-mitotic development and 
become recruited during running or swimming behaviors [90]. Their importance in locomotion 
makes V3 INs an key target to better understand locomotor coordination and a potential cell 
therapy candidate for functional recovery and local reorganization after spinal cord injury. 
Neurons of the ventral spinal cord have been generated from mouse ESCs by exposing 
embryoid bodies (EBs) to sonic hedgehog (Shh) pathway agonists and retinoic acid (RA) [6,99]. 
Shh forms a dorsal-ventral gradient in the neural tube during development and helps to establish 
the five ventral spinal progenitor domains, which then mature into post-mitotic spinal neurons 
[37,39,42,167]. RA from the lateral somites acts as a caudalizing factor to impart spinal identity 
[6,147,148]. The protocol to derive MNs from ESCs uses relatively high RA and Shh 
concentrations to induce spinal MNs [6,99,153]. To induce V3 INs, the p3 progenitor domain 
location was examined in relation to the progenitor MN domain location. Being a more ventral 
population, V3 INs sit closer to the floor plate and notochord, and therefore would be exposed to 
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increased Shh signal strength and duration [38]. Additionally, being further away from the lateral 
somites, V3 INs would be exposed to lower RA concentrations. While V3 INs can be generated 
via induction of mouse ESCs, the yield is relatively low (~8%) [166].  
Unfortunately, ESC differentiation protocols generally yield heterogeneous populations, 
and this heterogeneity makes live cell identification and characterization difficult. Heterogeneity 
also negatively affects transplantation – often generating teratomas and causing regression after 
short-term improvements due to incomplete cell differentiation or maturation [33-35]. Some 
methods to reduce this heterogeneity include density-based centrifugation, fluorescence-
activated cell sorting (FACS), and use of transgenic cell lines with antibiotic resistance. Density 
gradient-based MN separation protocols have been used to improve MN yield [168,169]. 
However, V3 INs are similar in size to many other IN populations, making isolation of V3 INs 
from other spinal cells difficult. FACS requires either a unique cell surface marker or genetic 
engineering of a fluorescent marker to isolate pure populations [170], and it is slow for 
purification of cells that make up a small percentage of the initial population (<10%) [171]. 
FACS also increases the risk for contaminated cultures and can result in low viability for post-
mitotic neurons. Antibiotic resistance has a long history within biology for positive selection of 
desired traits and is much more scalable compared to FACS. Additionally once an antibiotic 
resistant cell line line is generated, no specialized equipment is required for cell isolation. Cell 
lines for antibiotic resistance have been previously utilized for the enrichment of neural lineage 
populations [172,173]. Recently, our lab generated mouse ESC lines expressing puromycin-N-
acetyltransferase (PAC, a puromycin resistance gene) for the positive selection of induced neural 
progenitors and neuronal populations [153,174]. In these cell lines PAC was expressed either 
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under Olig2, a marker for progenitor MNs (pMNs), or Hb9, a marker for post-mitotic MNs. 
These cell lines utilized drug selection as a high throughput, low cost method to enrich cell 
populations for the desired cell type based on developmental marker expression. 
Using similar methods, this paper details an approach to obtain high purity V3 IN 
cultures. Our V3 selectable (Sim1-Puro) ESC line incorporated PAC into the Sim1 locus to allow 
positive selection for V3 INs after induction. Recombineering was used to generate a vector that 
incorporated the PAC gene into the first exon of Sim1, between two Sim1 homology arms. The 
transgene was knocked into one allele of the Sim1 gene after a Cas9/CRISPR targeting system 
induced a double stranded break, generating a cell line that enabled the selection of Sim1+ cells. 
Resulting V3 INs were confirmed to express the post-mitotic marker Sim1, the glutamatergic 
marker VGluT2, and neuronal marker -III tubulin. V3 INs exhibited neuronal maturation by 
electrophysiological measures, including decreasing resistance, increasing capacitance, and 
firing action potentials in response to current injections. After two weeks, they up regulated 
synaptic markers SV2, PSD95, and Bassoon, indicating their ability to form synapses. This cell 
line allows for an inexpensive and scalable method for isolating V3 INs for future study in vitro 
and for cell transplantation studies.  
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3.2 Materials and Methods 
3.2.1 ESC culture 
All ESCs were cultured on T-25 flasks coated in 0.1% gelatin (Sigma, St. Louis, MO). 
Cells were cultured in complete media consisting of Dulbecco’s Modified Eagle Medium 
(DMEM 11965, Life Technologies, Carlsbad, CA) containing 10% newborn calf serum (Life 
Technologies), 10% fetal bovine serum (Life Technologies), and a 1:100 dilution of a 100x 
nucleosides mix (EMD Millipore, Bellerica, MA). Cells were routinely passaged by washing 
with DMEM 11965 containing 25 mM HEPES (Life Technologies), dissociating with 1 mL 0.25% 
Trypsin EDTA (Life Technologies), quenching with complete media, and plating into a new T-
25 gelatin-coated flask containing a final volume of 5 mL media with 1000U/mL leukemia 
inhibitory factor (LIF; EMD Millipore) and 100 µM β-mercaptoethanol (Life Technologies). 
 
3.2.2 Generation of Sim1-Puro-pStartTK targeting vector 
The Sim1-Puro-pStartTK targeting vector was constructed following a previously 
published protocol [7]. The backbone was a Gateway-compatible plasmid, pStartK (Addgene, 
Cambridge, MA). Sim1 homology arms were incorporated into pStartK from RP23-223M2 BAC 
("BACPAC Resource Center", Children's Hospital Oakland Research Institute, Oakland, CA) 
using pstartK_Sim1_upstream and pstartK_Sim1_downstream primers (Table 3.1) by 
recombineering techniques with red recombinase competent bacteria (Sim1-pStartK, Fig. 3.1 A). 
A chloramphenicol resistance gene flanked by AscI cut sites from pkD3 (The E. Coli Genetic 
Stock Center, Yale University, New Haven, CT) was inserted into the open reading frame of the 
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Sim1 gene by recombineering with primers Sim1_CAT_Forward and Sim1_CAT_Reverse 
900bp (Table 3.1). The chloramphenicol resistance gene was then replaced via restriction 
enzyme digestion and ligation by a dual resistance cassette consisting of, from 5’ to 3’: Asc1 cut 
site, Kozak sequence, PAC with bgh polyA signal, floxed phosphoglycerate kinase I promoter 
driving neomycin phosphotransferase (PGK-neo) with bgh polyA signal, and AscI site (gift from 
Dr. David Gottlieb, Washington University, St. Louis, MO) [153]. A negative selection 
thymidine kinase gene was incorporated into the finished vector (Sim1-Puro-pStartTK, Fig. 3.1 
B) using pWS-TK3 plasmid (Addgene) and Gateway LR clonase II kit (Life Technologies). 
 
Table 3.1: Primers for Sim1-Puro Generation 
 
Primer Name Sequence 
pstartK_Sim1_u
pstream 
AAAGTACTGTTTCTGGGGAAAACTCTAGTTTAGAGACCCTCCTGTTCTA
Acgactgaattggttcctttaaagc 
pstartK_Sim1_d
ownstream 
GAACCAGGCAGAGGGAAAGCTTCTCATTAGTGCTTTTCCCTTCTCTCT
CCgccgcactcgagatatctagaccca 
Sim1_CAT_Forw
ard 
GATGAGTCTGTGGAGTTTACGTTGTAAGAAGAAAGGGAGCCCGAGAC
ACGGGCGCGCCagcattacacgtcttgagcgattgt 
Sim1_CAT_Reve
rse 900bp 
TTGAGGAAGGGTGAGCAAATGGGAGATCAAAGAGCTCCTTCCCTGGA
GAGGGCGCGCCcacttaacggctgacatgggaatta 
Sim1_Fwd_Junc
tion1 
atgcacacgactcttcaaagaa 
Puro_Reverse 
Junction1 
gcgccaggaggccttccatctgttgct 
Capital letters indicate homology arms for red recombination.  
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3.2.3 Generation of Sim1-Puro ESCs 
The Sim1-Puro cell line was generated from the RW4 mouse ESC line (American Type 
Culture Collection, Manassas, VA). Approximately 1×107 RW4 ESCs were resuspended in 
electroporation buffer with 10 μg of Sim1-Puro-pStartTK vector, and 200-300 ng of a Cas9 
guide RNA vector (deemed gSim1.MS8.mSim1.g6a, with guide RNA (Fig. 3.1C, Cas9 Guide 
RNA) targeting 5' gtccatcattcgtgtcttcc cgg 3' near the Sim1 start codon (Fig. 3.1 C, Cas9 Target)) 
in the MLM3636 plasmid (Addgene plasmid #43860) and 200-300 ng of the Cas9 nuclease 
expression plasmid p3s-Cas9HC (Addgene plasmid #43945). Both Cas9 vectors were from 
Genome Engineering Core, Washington University in St. Louis and originally gifted by Keith 
Joung and Jin-Soo Kim, respectively. Cells were electroporated using a Biorad Gene Pulser 
Xcell Eukaryotic System at 0.23kV and 975μF in a 0.4 cm cuvette (Bio-Rad, Hercules, CA). 
Following electroporation, cells were seeded on gelatin-coated 100 mm dishes for 24 hours then 
treated with G418 (200 μg/ml, Life Technologies) and 1-(2-Deoxy-2-fluoro-β-D-
arabinofuranosyl)-5-iodouracil (FIAU; 150 nM, Movarek Biochemicals, Brea, CA) for positive 
and negative selection, respectively. After 14 days, surviving clones were picked and seeded into 
individual wells of a gelatin-coated 96 well plate.  
 
3.2.4 PCR screening on Sim1-Puro clones 
Clones were screened for targeting events by junction polymerase chain reaction (JPCR, 
Fig. 3.1D). One primer binding outside of the left homology arm (5’ HA, Fig. 3.1D) and the 
other primer binding inside the PAC gene were used to screen for clones that properly 
incorporated the PAC gene. Reactions were performed using a Mastercycler Nexus Gradient 
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thermocycler (Eppendorf, Hauppauge, NY) with primers Sim1_Fwd_Junction1 and 
Puro_Reverse Junction1 (Table 3.1 and Fig. 3.1 D) at 95°C for 60s, followed by 35 cycles of 
94°C for 20s, 60°C for 30s, and 72°C for 120s.  
 
3.2.5 Copy number assay 
Taqman Copy number assay (Life Technologies) was performed on cell lysates as per 
manufacturer instructions. Gapdh (Mm00186825_cn, Life Technologies) was normalized to 
RW4 ESCs, and PAC (custom ordered PAC assay, Life Technologies) was normalized to a 
previously published Hb9-Puro cell line [174]. Analysis was performed using Life Technologies 
CopyCaller v2.0.  
 
3.2.6 V3 IN induction 
RW4 ESCs and Sim1-Puro ESCs were aggregated to form EBs on a non-adhesive agar-
coated surface and induced to generate neural progenitors using our previously established 8 day 
induction protocol (2-/6+, where “2-” refers to the number of days ES cells are allowed to 
aggregate into EBs without (-) RA and smoothened agonist (SAG, a Shh pathway agonist) and 
“#+”refers to the number of days the EBs are exposed to (+) RA and SAG; Fig. 3.2A) [166]. 
Cells were cultured in suspension for two days on 100 mm Petri dishes pre-coated with 0.1% 
agar (Thermo Fisher Scientific, Waltham, MA) in DFK-5 media comprised of 1:1 DMEM/F12 
(Life Technologies) with 5% knockout serum replacement (Life Technologies), 1x insulin 
transferrin selenium (Life Technologies), 100 μM β-mercaptoethanol, 50 μM nonessential amino 
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acids (Life Technologies), and a 1:200 dilution of a 100x nucleosides mix. During the first two 
days, the cells aggregate into multi-cellular EBs. After aggregation, EBs were removed and 
allowed to settle. The supernatant was discarded and replaced with new DFK-5 media 
supplemented with 10 mM RA (Sigma) and 0.5 μM SAG (EMD, Millipore). Media was replaced 
every two days for six days.  
 
3.2.7 Selection and differentiation of V3 INs 
To test PAC expression in Sim1+ cells, RW4 and Sim1-Puro EBs were subjected to 
induction and selection protocols as illustrated in Fig. 3.2A. On 2-/4+, standard tissue culture 
plates were pre-coated with 0.01% poly(ornithine) solution (Sigma) at 37°C for 1 hour. 
Poly(ornithine) was removed and plates were washed with a HEPES buffered saline solution 3 
times. Plates were then coated with 0.01 mg/mL laminin (Life Technologies) in HEPES buffered 
saline solution overnight and washed 3 times before use as laminin coated plates. One day prior 
to the end of V3 IN induction (on 2-/5+), EBs were allowed to settle, and the DFK-5 media 
supernatant was collected. EBs were dissociated with 0.25% trypsin-EDTA for 15 minutes at 
37°C, quenched with complete media, pelleted and replated at 3.5x107 cells/cm2 onto laminin-
coated plates. Cells were incubated with 2 µg/mL puromycin (Sigma) in the collected DFK-5 
supernatant for 1 day (designated as 1p, Fig. 3.2A). After one day, puromycin-containing media 
was removed and replaced with “P-Olig2-conditioned” media (see next section) with 
supplemental factors (1x Glutamax (Life Technologies), and 5 ng/mL each of NT-3, GDNF, and 
BDNF (all from Peprotech, Rock Hill, NJ). Cells were allowed to differentiate up to 14 days 
(designed as “+ #” where # is the number of days after selection, Fig. 3.2A). 
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3.2.8 Generation of P-Olig2-Conditioned V3 media for long term V3 cultures 
After selection, cells were initially cultured in a 1:1 mix of DFK-5 and Neurobasal (Life 
Technologies) media with supplemental factors (listed above). However, due to the low cell 
density, extensive cell death was observed between 3 and 7 days post-selection (1p +3 and 1p 
+7). Thus, to improve cell survival, conditioned media generated by progenitor motor neuron 
cultures containing glia (oligodendrocyte and astrocytes) was used. A puromycin-selectable-
pMN ESC line (P-Olig2), with PAC knocked into the Olig2 locus, underwent 2-/4+ induction 
using DFK-5 media with 2 µM RA and 0.5 µM SAG (2 days without and 4 days with RA/SAG) 
as previously described [153]. On the last two days of pMN induction (2−/2+ - 2−/4+), cells were 
selected with 4 µg/mL puromycin. On 2−/4+, the selected EBs were dissociated and plated at a 
density of 100,000 cells/mL in a 1:1 mix of DFK-5 and Neurobasal media with 1x B27 (Life 
Technologies) in a 6 well laminin-coated plate. Conditioned media was collected and replaced 
with fresh media every two days. Selected P-Olig2 cells were cultured up to 14 days.  
 
3.2.9 Live assay 
Live reagent, calcien-AM (Life Technologies), was used to visualize live cells, 
respectively. Wells were washed with DMEM 11965 containing 25 mM HEPES and incubated 
with 0.325 µL/mL of 4 mM stock concentration calcien-AM (live) for 30 min at room 
temperature.  
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3.2.10 Probe synthesis for in situ hybridization 
Plasmids for in situ hybridization probes were a generous gift from Dr. Paul Gray 
(Washington University in St. Louis) [155]. Gene fragments from verified plasmids were 
linearized by direct PCR amplification using ReadyMade Primers (SP6 Promoter and T7 
Promoter, Integrated DNA Technologies, Coralville, IA). Digoxigenin (DIG)-labeled antisense 
and sense RNA probes were made using PCR products as template and T7 RNA polymerases 
(Roche, Indianapolis, IN). Probes were used at a concentration of 1–2 μg/ml. Sense counterparts 
of all probes were tested to ensure probe specificity. 
 
3.2.11 In situ hybridization 
To assess the purity of cells post selection, in situ hybridization was performed on 
dissociated cells. After 24 hours of selection, cultured cells were fixed in 4% paraformaldehyde 
(PFA) for 10 minutes and washed 3 times in diethylpyrocarbonate (DEPC, Sigma) treated PBS at 
room temperature. Next, cells were incubated in 0.1 M triethanolamine-HCl (1.3% triethanol 
amine (Sigma) and 0.4% HCl (Thermo Fisher Scientific) with 0.25% acetic anhydride (Sigma)) 
for 10 minutes. Cells were washed in 1x sodium citrate buffer for 5 minutes at room temperature 
and permeabilized in 0.2M HCl in DEPC-water for 10 minutes. 3 additional washes with DEPC 
treated PBS were performed before cells were blocked in hybridization buffer (50% 
formaldehyde (Sigma), 5x sodium citrate buffer (SSC, Life Technologies), 0.3 mg/mL yeast 
RNA (Sigma), 0.1 mg/mL heparin (Sigma), 1x Denhardt’s solution (Life Technologies), 0.1% 
tween (Sigma) and 5 mM EDTA) for 4-6 hours at room temperature. Cells were incubated in 
hybridization buffer containing 1–2 μg/mL DIG-labeled antisense RNA probes (see previous 
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section) overnight at 65°C. Probed cells were washed in twice in 0.2× SSC at 62°C, and 
incubated in 0.2× SSC for 60 minutes at 65°C. Washed cells were adjusted to room temperature 
and blocked with 10% deactivated horse serum (Life Technologies) in phosphate buffered saline 
with 2 mg/mL bovine serum albumin and 0.1% Triton X-100 (PBT) and incubated in alkaline 
phosphatase-labeled anti-DIG antibody (1:2000 in 10% deactivated horse serum in PBT; Roche) 
overnight. Cells were further washed with PBT and color was visualized using nitro blue 
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Roche). Staining was stopped with 4% 
PFA after visual inspection. Cell nuclei were stained with the nuclei binding dye Hoechst 
(1:1000 Life Technologies).  
 
3.2.12 Immunocytochemistry 
Neuronal cell identity was assessed in differentiated cultures using immunocytochemistry. 
Cell cultures were fixed with 4% PFA for 30 min then permeabilized in 0.01% Triton X (Sigma) 
for 15 min. The cells were blocked with 5% NGS for 1 hour at 4°C and incubated overnight at 
4°C in 2% NGS solution with one or more of the following primary antibodies: rabbit anti-Tuj1 
(for - III tubulin, 1:200, Covance, Princeton, NJ), guinea pig anti-VGluT2 (1:3000, EMD 
Millipore), mouse anti-SV2 (1:100, Developmental Studies Hybridoma Bank), rabbit anti-MAP2 
(1:1000, EMD Millipore), mouse anti-bassoon (1:600, Enzo Life Sciences, Farmingdale, NY). 
Primary antibody staining was followed by 3 washes in an excess volume of PBS for 15 min 
each. Each culture was then stained with appropriate Alexa Fluor secondary antibodies (1:1000; 
Life Technologies) for 1 hour at 4°C followed by an additional 3 washes in PBS. Cell nuclei 
were stained with Hoechst (1:1000).  
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3.2.13 Image capture and analysis 
All images were captured using a MICROfire camera (Olympus, Center Valley, PA) 
attached to an Olympus IX70 inverted microscope using either a 10x or 20x objective. Images 
were merged and colored using ImageJ (U. S. National Institutes of Health, Bethesda, Maryland, 
USA). To remove human bias, ImageJ was used for the automated counting of Hoechst-labeled 
nuclei. Images underwent thresholding to remove background, then were converted to binary 
black and white images. The “Analyze Particles” function was used to count the nuclei, 
excluding any small (less than 600 pixels) punctate nuclei to prevent apoptotic Hoechst+ nuclear 
debris from being counted.  
 
3.2.14 Quantitative real-time PCR (qRT-PCR) 
Fourteen days after selection (1p +14), selected and unselected (control) cells on a 24-
well plate were lysed with 350 μL of buffer RLT from the RNeasy Mini Kit (Qiagen, Valencia, 
CA). High Capacity RNA-to-cDNA Kit (Life Technologies) generated cDNA from RNA that 
was extracted per Qiagen’s instructions. TaqMan Fast Advanced Master Mix (Life Technologies) 
was combined with TaqMan Gene Expression Assays (Life Technologies; Table 3.2) and cDNA 
for qRT-PCR. Reactions were performed using a Step One Plus Applied Biosystems 
thermocycler (Life Techonologies) with the default protocol: 95°C for 20s, 40 cycles of 95°C for 
1s and 60°C for 20s. The number of cycles necessary for the fluorescent intensity to increase 
exponentially, Ct values, were recorded and normalized to β-actin expression. The comparative 
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ΔCt method [154] was used to analyze the mRNA expression levels compared to undifferentiated 
Sim1-Puro ESCs. Fold differences in relative mRNA expression levels over the control cultures 
are reported for each gene (n ≥ 3 for all groups). 
 
Table 3.2: TaqMan Gene Expression Assays for qRT-PCR 
Marker Life Tech Identification 
Bassoon Mm00464452_m1 
Beta-Actin Mm00607939_S1 
Psd95 Mm00492193_m1 
SV2a Mm00491537_m1 
VGluT2 Mm00499876_m1 
 
3.2.15 Electrophysiology  
Whole-cell electrodes had an open tip resistance of 2 to 6 MOhms when filled with K- or 
Cs-glucuronate internal solutions (in mM, all from Sigma): 140 K-glucuronate 10 NaCl, 5 MgCl2, 
0.2 EGTA, 10 HEPES, pH adjusted to 7.4 with KOH; or, 130 Cs-glucuronate, 5 MgCl2, 0.2 
EGTA, 10 HEPES, pH adjusted to 7.4 with CsOH. Both internal solutions were supplemented 
with 5 mM Na-ATP and 1 mM Na-GTP. Culture dishes were perfused at ~ 1 ml/min with 
Tyrode’s solution (in mM): 150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 glucose, 10 HEPES, pH 
adjusted to 7.4 with NaOH. Currents and membrane potentials were recorded with Axopatch 200 
amplifiers (Molecular Devices, Sunnyvale, CA), filtered at 1 kHz and digitized at 10 kHz using 
pClamp 9.2 (Molecular Devices, Sunnyvale, CA). Tetrodotoxin (TTX, 0.5 µM), 
tetraethylammonium (TEA, 30 mM) and 4-aminopyridine (4-AP, 5 mM) were dissolved in 
64 
 
Tyrode’s. Agonists were dissolved at 100 µM in 160 mM NaCl, 2 mM CaCl2, 10 mM HEPES, 
pH adjusted to 7.4 with NaOH. Drug solutions were applied by local perfusion from a multi-
barreled delivery pipette [148]. 
 
3.2.16 Statistical analysis 
Three biological replicates of each condition were performed. Three sample pictures were 
analyzed from each replicate for cell counting. Statistical analysis was performed in Statistica 
software (version 5.5; StatSoft, Tulsa, OK). Unless otherwise stated, multiple comparisons 
statistics were accomplished using Scheffe’s post hoc test for analysis of variance (ANOVA) 
with a 95% confidence level. Values are reported as the mean plus or minus standard deviation. 
 
3.3 Results and Discussion 
While ESCs provide a plentiful cell source to better study a variety of cell types, the 
heterogeneity of cells induced from ESC cultures by current protocols retains the problems of 
dissection and isolation. Recently, our lab reported a MN line where previously established Hb9 
enhancer regions were used to drive expression PAC [174]. Unfortunately, a highly conserved 
efficient enhancer region for Sim1 has not been identified [175]. Thus, random insertion of a 
Sim1 enhancer-promoter driving PAC was not achievable. Homologous recombination has been 
used ubiquitously to generate knockout animals and cell lines [7]. Previously, our lab reported a 
Olig2-Puro cell line that has PAC knocked into the Olig2 locus, enabling the Olig2 gene 
regulatory elements to control PAC expression [153]. This method was adopted for the Sim1 
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locus, such that transgenic mouse ESCs were generated by the electroporation of a vector 
containing the PAC gene into the Sim1 locus. The use of Cas9/CRISPR technology greatly 
increased the efficiency of recombination by inducing a double strained break in the first exon of 
Sim1. This paper describes a method to overcome the heterogeneity of ESC-derived V3 IN 
cultures using this Sim1-Puro ESC line.  
 
3.3.1 Targeted PAC insertion into the Sim1 locus 
The Sim1-Puro cell line was generated by using a targeting vector to insert a resistance 
cassette into the open reading frame of the Sim1 gene. Two homology arms ~ 2 kb and 10 kb in 
size were inserted into the targeting vector flanking the resistance cassette (Fig. 3.1A-B). RW4 
ESCs were electroporated with the targeting vector and a set of Sim1 targeting Cas9/CRISPR 
plasmids. The expected homologous recombination event is illustrated in Fig. 3.1C. JPCR with 
one primer hybridizing to genomic DNA outside of the homology arms and one primer 
hybridizing within the resistance cassette was used to screen for insertion of the resistance 
cassette into the Sim1 locus (Fig. 3.1D-E). 
While Sim1-Cre heterozygous animals have been reported with appropriate neuronal 
migration, in Sim1 knockout mice, the neurons fail to properly migrate [176]. Furthermore, 
Sim1-/- animals are not viable [176], further indicating the importance of keeping at least one 
allele of Sim1 intact. Thus, it was important that only one allele had the puromycin gene knocked  
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Figure 3.1: Generation and identification of Sim1-Puro cell line. A) Red recombineering was 
utilized to insert the region ~ 2 kb upstream to ~10 kb downstream of Exon 1 of the Sim1 gene 
from RP23-223M2 BAC into the pStartK backbone, generating the Sim1-pStartK plasmid. B) 
After AscI cut sites were introduced by another red recombination reaction, a PAC-PGK-Neo 
cassette was inserted into the open reading frame of Sim1 Exon1in the Sim1-pStartK plasmid. 
Using gateway recombination, the pStartK backbone was replaced with the pWS-TK3 backbone 
to introduce the negative selection gene, TK. 5’ and 3’ homology arms are labeled. C) 
CRISPR/Cas9 targeting of the Sim1 gene was used to generate a double stranded break at the 
desired recombination location. Sim1-Puro-pStartTK recombined into the Sim1 locus as shown 
by the dotted lines. 5’ and 3’ homology arms are labeled. D) The Sim1-Puro cell line with PAC 
in Sim1 Exon 1. Junction PCR (JPCR) primers for approximately 2.6 kb was used to screen for 
the desired recombination event. E) Junction PCR bands of positive (+) and negative (-) clones 
with a 1kb ladder. F) Copy number assay shows Sim1 clones have one copy of PAC by 
comparison with RW4 ESCs and Hb9-Puro ESC controls. Abbreviations: AMP, ampicillin 
resistance gene; AscI, restriction enzyme site; attB1 & attB2, gateway recombination results; 
HA, homology arm; JPCR, junction PCR; ori, origin of replication; PAC, puromycin resistance 
gene; PGK, phosphoglycerate kinase promoter sequence; Neo, neomycin resistance gene; Sim1 
ATG, translation start in Sim1 Exon1; TK, thymidine kinase. 
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into the Sim1 locus. Two clones (6E and 8E) that screened positive for insertion of PAC by 
JPCR were analyzed with a copy number assay, which reported values of ~ 1 for both clones 
(Fig. 3.1F), indicating that only one copy of the PAC gene was inserted into the cells, and that 
other Sim1 allele did not have PAC knocked in. The appropriate JPCR results coupled with the 
copy number assay results together indicate that one copy of PAC was successfully inserted into 
the Sim1 locus, resulting in the desired Sim1-Puro cell line. The resulting transgenic-ES cell line 
(Sim1-Puro Clone 6E) was used for all subsequent studies. 
 
3.3.2 Increased purity of Sim1+ cells after puromycin selection 
To test for PAC expression in Sim1+ cells, RW4 and Sim1-Puro EBs were subjected to 
induction and selection (2-/6+/1p) protocols as illustrated in Fig. 3.2A. Visual assessment of 
calcein-AM staining of selected and unselected cultures showed that 2 µg/mL puromycin was 
sufficient to kill all RW4 cells. The unselected RW4 culture (Fig. 3.2B) looked healthy and 
confluent, while the selected RW4s had no remaining live cells (Fig. 3.2C). In the Sim1-Puro 
selected and unselected cultures, the unselected cultures contained many cells of non-neuronal 
morphology, while the selected culture contained fewer cells with non-neuronal morphology (Fig. 
3.2D-E). The efficacy of RW4 selection indicated that the 2 µg/mL puromycin concentration had 
sufficient potency to remove all non-PAC-expressing cells but allowed survival of PAC 
expressing cells, whereas 4 µg/mL puromycin resulted in very low cell viability (data not shown). 
Thus, 2 µg/mL puromycin was used for subsequent studies.  
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Figure 3.2: The effect of selection on survival of RW4 and Sim1-Puro ES cells. A) Diagram 
depicting induction and selection process. Induction and differentiation nomenclature is 
indicated by parenthesis while the time course (in days) is denoted by the time line. Briefly, ES 
cells are allowed to aggregate for 2 days (2-) to form EBs. EBs are induced with RA and Shh for 
5 days (5+) and selected with puromycin in the presence of RA and Shh for 1 day (6+/ 1p). 
Selected cells are allowed to differentiate after selection (1p + #). B & D) Live (calcein-AM) 
staining on unselected cells. C & E) Live staining of selected cells. Scale bar = 50 µm. 
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Figure 3.3: Puromycin selection increases the percentage of cells expressing Sim1 in Sim1-Puro 
cultures. A-C) Sim1 in situ hybridization (dark cell bodies) and nuclear staining (blue) on 
unselected cells. D-F) Sim1 in situ hybridization and nuclear staining on selected cells. A&D) 
Sim1 in situ hybridization. B&E) Nuclear marker Hoechst (blue). C&F) Overlaid images. G) 
Selected cultures enriches for percentage of Sim1+ cells. * denotes p <0.05 compared to 
unselected group.  
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Due to the lack of a specific Sim1 antibody, the purity of cultures post-selection was 
assessed by performing in situ hybridization on dissociated cultures. The percentage of Sim1+ 
cells increased significantly from 11% in unselected cultures to 83% after selection (Fig. 3.3). 
This increase indicated that puromycin selection of the Sim1-Puro line successfully enriched for 
Sim1+ cells. Furthermore, the presence of Sim1+ cells via in situ hybridization corroborates the  
copy number assay data and suggests that the Sim1 gene on the non-altered allele should be 
functional, at least to the properly spliced mRNA stage. 
Based on the in situ hybridization results, the Sim1-Puro cell line is able to enrich a 
culture for Sim1+ cells, such that most of the cells in a selected culture are Sim1+. The purity of 
the selected Sim1-Puro line is lower compared to the 99% purity of MNs reported from the Hb9-
Puro line previously generated in our lab. One reason for lower purity is that the Hb9-Puro line 
was assessed with an antibody while the Sim1-Puro line was assessed with in situ hybridization – 
a mRNA based technique. Because mRNA is transient and expressed prior to protein synthesis, a 
portion of the surviving cells could be Sim1 mRNA negative but have recently expressed Sim1 
mRNA and thus still have Sim1 and PAC protein present. They would not be Sim1+ by in situ 
hybridization, but would still be V3 INs and might stain positive with a Sim1 antibody, if one 
existed. Another reason for having a lower percentage of Sim1+ cells is that, compared to the 
Hb9-Puro study, a lower puromycin concentration was used in this study for selection. 
Previously, 4 µg/mL puromycin was used in for the Hb9-Puro cell line and 2 µg/mL was used 
here with the Sim1-Puro cell line because less than 100 cells/cm2 was observed after 4 µg/mL 
puromycin selection. Hb9 mRNA levels increase ~400 fold versus uninduced controls (no RA 
and no SAG) after MN induction, whereas Sim1 mRNA levels only increase ~100 fold after 
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induction [153,166], suggesting that Sim1 is not as strongly expressed as Hb9. This fold change 
difference can be partially attributed to the lower induction protocol efficiency (~60% for MNs 
vs ~10% for V3 INs), but it could also be due to Sim1 gene regulatory elements driving less 
robust expression than those for Hb9 . Lower levels of PAC expression in each cell could result 
in increased sensitivity at a lower puromycin concentration. While the resulting cultures are not 
100% Sim1+ cells, the observed enrichment is sufficient to allow for further studies of ESC-
induced V3 INs. 
 
3.3.4 Selected cultures exhibit neuronal markers and achieve functional 
maturity 
Glial-conditioned media was needed for the long-term survival of selected Sim1-Puro V3 
INs. Initially, without conditioned media, we observed axonal degeneration by 7 days in culture 
and ultimately cell death. We hypothesized that providing glial signaling cues would aid in V3 
IN survival. Thus, the P-Olig2 ESC line, where the PAC gene was incorporated into the Olig2 
locus was used to obtain glia and to produce conditioned media. Selection of P-Olig2 cells 
results in both MNs and glia (oligodendrocytes and astrocytes)[153]. While this was not ideal for 
generating a high purity MN population, the resulting pMN population generated glial-
conditioned media suitable for long-term cultures of V3 INs. Using this conditioned media, V3 
IN cultures survived for more than 14 days, which was necessary for maturation and synapse 
formation to be observed.  
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Figure 3.4: Sim1-Puro cultures exhibit glutamatergic and neuronal markers through the first 
week post-selection. A-D) Staining 3 days post selection. E-H) Staining 7 days post selection. 
Immunocytochemistry marker labeled on far left. A&E) β-III Tubulin (red in combined); B&F) 
VGluT2 (green in combined); C&G) Combined image; D&H) Zoomed in combined image. 
Scale bar = 100 µm. 
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To assess the phenotype selected cultures, immunocytochemistry was performed. β-III 
tubulin was used to verify the neuronal identity of the selected cells. As seen in Fig. 3.4 A and E, 
selected cells express β-III Tubulin with axonal morphology at both 3 and 7 days post selection 
(1p +3 and 1p +7). VGluT2, a vesicular glutamate transporter found in synaptic vesicles at 
presynaptic nerve terminals of excitatory neurons, was used as as a marker of glutamatergic  
neurons. As seen in Fig. 3.4 B and F, selected cells exhibited punctate VGluT2 staining along 
their axons at 3 and 7 days post selection. The VGluT2 and β-III tubulin staining aligned well 
(Fig. 3.4 C&D), and the VGluT2 puncta are clearly visible in the zoomed in insets (Fig. 3.4 
G&H). These two antibodies verify that the selected cells are indeed glutamatergic neurons.  
Because these images were taken 4 days apart, some disparities between the left and right 
columns of Fig. 3.4 were expected. We expected to observe maturation of axonal processes 
(longer axons and more connectivity between each other), which can be observed in Fig. 3.4G. 
Furthermore, at 7 days post-selection, the cells are more sparsely distributed. This is not 
unexpected due to pruning observed in neuronal development. While some debate is present in 
the literature over whether INs undergo apoptosis as observed in MNs, it has been shown that 
ventral spinal INs do undergo apoptosis after they become post-mitotic [176,177]. This occurs 
generally between e14 and P0 [176]. Our induction ends (1p +0) when Sim1 is strongly 
expressed, roughly equivalent to e11.5 [88], so apoptosis would be expected in the ensuing week. 
Taken together, the differences between the left and right columns of Fig. 3.4 are consistent with 
expected neuronal maturation.  
To determine whether selected V3 INs are maturing, immunocytochemistry was 
performed on cultures 2 weeks post selection. MAP2, a dendritic marker, was used to identify  
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Figure 3.5: Sim1-Puro cultures exhibit synaptic marker protein and mRNA expression after 2 
weeks. A-F) 2 week selected cultures stained with dendritic marker MAP2 and synaptic markers, 
SV2 and Bassoon. Synaptic markers (B and E, red) exhibit puncta that overlap with MAP2 (C 
and F, white arrows) suggesting synapse formation. Scale bar = 50 µm. G) 2 week selected 
cultures express increased synaptic marker (Bassoon, PSD95, and SV2) and VGluT2 
(glutamatergic neuron) mRNA levels compared to unselected cultures (normalization control - 
Sim1-Puro ESCs). * denotes p <0.05 compared to the unselected group.  
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neurons in culture. SV2 and Bassoon staining shows positive, punctate, synaptic marker staining 
along axons, indicating potential synapse formation (Fig. 3.5 A-F). The presence of positive 
synaptic marker staining within the cell body was not expected. We hypothesized that if the 
synaptic marker mRNA was still being expressed, protein translation could be in progress and  
result in positive staining of the cell body. Thus, qRT-PCR was performed on 1p +14 (2 week 
post-selection) to assess expression levels of synaptic markers. Synaptic markers SV2, Bassoon, 
and PSD95, as well as glutamatergic neuron marker, VGluT2 were assessed in selected and 
unselected cultures. The resulting qRT-PCR data shows an upregulation of all markers in all 
conditions compared to the ESC controls and an increase in all marker expression between 
selected and unselected cells (Fig. 3.5 G). These results must be considered within the context of 
a population-averaged assay. While the results suggest that there are more cells expressing 
synaptic markers in selected versus unselected cultures, the data only indicate that in selected 
cultures there is a greater percentage of neurons than in unselected cultures. This is due to 
normalization of the data to the internal control -actin, effectively normalizing expression 
levels to cell count. Additionally, the relative low levels of synaptic marker expression suggest 
that neurons within the cultures at 2 weeks are working towards but have not yet formed mature 
synapses.  
 
3.3.5 Electrophysiology 
In addition to using immunocytochemistry to characterize the Sim1-Puro line, 
electrophysiological recordings of the selected cells were also used to assess maturation. Whole-  
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Table 3.3: Electrophysiological properties of Sim1-Puro selected cells. 
Parameter P + 2-5 P + 6-13 MN Properties
^ 
Capacitance (pF) 18.3 ± 1.3 (51) 24.2 ± 0.9 (68) * 31.3 ± 1.1 
Input Resistance 
(GOhm) 
1.64 ± 0.49 (51) 0.96 ± 0.17 (68) * 
0.570 ± 0.028 
V rest (mV) -28.5 ± 2.1 (43) -43.7 ± 1.2 (64) * -53 ± 1 mV 
% V rest <-50 mV 5% 28% * >50% 
Rheobase (pA) 10.6 ± 2.3 (14) 18.3 ± 2.7 (34) -- 
1st spike latency (msec) 214 ± 43 (14) 153 ± 19 (24) -- 
1st spike amplitude (mV) 84 ± 4.5 (14) 95 ± 3.5 (24) -- 
absolute amplitude (mV) 23 ± 4.1 (14) 34 ± 3.5 (24) -- 
1st spike threshold (mv) -35.6 ± 0.8 (14) -37.4 ± 0.9 (24) -- 
1st spike width (msec) 4.4 ± 0.5 (14) 2.9 ± 0.3 (24) * -- 
10 Hz 1st latency (msec) 44 ± 3.2 (14) 37 ± 2.0 (24) -- 
10 Hz 1st frequency (Hz) 11 ± 0.3 (14) 12 ± 0.3 (24) * -- 
10 Hz frequency adaptation 1.2 ± 0.04 (14) 1.3 ± 0.05 (24) -- 
10 Hz after potential (mv) 0.9 ± 0.5 (14) -0.9 ± 0.7 (24) -- 
f-I slope 1st interval 0.59 ± 0.07 (14) 0.44 ± 0.03 (24) -- 
f-I slope average frequency 0.54 ± 0.07 (14) 0.36 ± 0.03 (24) -- 
Sag at -90 mV (mV) 3.3 ± 1.1 (14) 3.3 ± 0.7 (24) -- 
Peak I Na (nA) -1.06 ± 0.12 (40) -2.09 ± 0.16 (58) * -- 
Vm for peak I Na (mV) -21.0 ± 1.6 (40) -26.1 ± 1.4 (58) * -- 
 
Values presented as mean ± SEM (number of cells). * denotes significantly different from P + 2-
5d by t-test, Mann-Whitney rank sum test, or Z-test. Cell capacitance and input resistance were 
determined from 10 mV voltage clamp steps from a holding potential of -80 mV. First spike 
latency, amplitude, absolute amplitude, threshold and half-width were determined for the first 
spike recorded at threshold depolarization. In addition, 800 msec depolarizations that elicited 
spiking with an average frequency of 10 Hz were used to measure 1st latency, instantaneous 
frequency from the first inter-spike interval (ISI), frequency adaptation (ratio of last to first ISI), 
after potential as well as the initial slope of frequency versus current (f-I) plots of instantaneous 
and average frequency. Sag in voltage responses was determined for 800 msec hyperpolarizing 
current injections from -60 mV. ^ Select properties acquired from ESC derived MNs, reported by 
Miles et al. 2004 [100] and McCreedy et al. 2014 [174].   
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Figure 3.6: Sim1-Puro selected cultures exhibit action potential firing and voltage gated currents 
consistent with neuronal maturation. (A) Sub- and supra-threshold voltage responses recorded 
under current clamp in a 1p +2 cell with 50 msec square pulse injection (6 and 8 pA). (B) 
Examples of cells firing single (1p +11), adapting (1p +11) and multiple (1p +10) action 
potentials during an 800 msec depolarizing pulse (44 pA). (C) Currents mediated by 
tetrodotoxin-sensitive sodium channels evoked by steps from -100 to +60 mV from a holding 
potential of -80 mV. (below) Peak inward current plotted as a function of step potential (1p +13; 
Cs-glucuronate internal solution). (D) Outward currents mediated by voltage-gated potassium 
channels for steps from -100 to +60 mV from a holding potential of -80 mV recorded in 0.5 µM 
TTX alone and in TTX plus 5 mM 4AP. (below) 4AP-sensitive currents revealed by subtracting 
current in TTX and 4AP from current in TTX alone (1p +8, K-glucuronate internal solution). (E) 
Current-voltage relation for steady-state (SS) current recorded in TTX plus 4AP (open symbols) 
and for peak 4AP-sensitive current (filled symbols).  
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than 60 additional cells between 6 and 13 day post-selection (1p +6 to 1p +13; late). Cell 
capacitance increased and input resistance decreased with time after selection consistent with an 
increase in cell size (Table 3.3). Resting membrane potential (Vrest) became more negative with 
time as did the proportion of cells that maintained Vrest less than -50 mV without the need for DC 
hyperpolarization. As shown in Fig. 3.6, depolarizing current injection elicited action potentials 
in cells as early as 2d after puromycin selection. With DC hyperpolarization to -60 mV and long 
duration (800 msec) depolarizing current pulses, all 14 of the early (1p +2 to 1p +5) cells tested 
were able to fire multiple action potentials, 57% showed prominent spike adaptation, and the 
remaining 43% fired repetitively with little adaptation. Most late (1p +6 to 1p +13) cells (70%) 
also fired multiple spikes, however 30% only fired single action potentials. For cells that 
produced multiple spikes the firing properties (Table 3.3) were more similar to the ventral than 
the dorsal V3 interneuron population as characterized in mouse spinal cord slices [90,91].  
Under voltage clamp, Sim1-Puro selected cells exhibited fast transient inward current and 
slow rising transient and sustained outward currents with depolarizing voltage steps from a 
holding potential of -80 mV (Fig. 3.6). Inward current was blocked by the selective sodium 
channel antagonist, tetrodotoxin (TTX, 0.5 µM). Outward current was reduced in cells filled with 
the potassium channel blocker cesium, or by extracellular exposure to the organic potassium 
channel blockers, tetraethylammonium (TEA, 30 mM) and 4-aminopyrridine (4-AP, 5 mM). As 
observed in other cell types [178], TEA inhibited sustained outward currents, while 4-AP 
reduced transient outward current. These results indicate the Sim1-Puro cells are expressing 
functional ion channels and behave in an appropriate manner for glutamatergic neurons. 
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Figure 3.7: Excitatory and inhibitory agonists activate appropriate whole-cell currents in Sim1-
Puro selected cultures. A) Whole-cell currents evoked by kainate (K), GABA, glycine (Gly) and 
NMDA (N; with 1 µM added glycine). Holding potential, -80 mV. B) Agonist-evoked currents 
recorded during voltage ramps from -100 to +50 mV at 1.2 mV/msec. GABA and glycine 
evoked current that reversed polarity at -48.6 +/- 2.0 mV (n=21) and -47.7 +/- 2.2 mV (n=10), 
respectively, consistent with activation of channels selective for chloride. Kainate and NMDA 
evoked currents reversed at -1.4 +/- 5.4 mV (n=24) and -5.3 +/- 7.2 mV (n=4), respectively, 
consistent with activation of cation selective channels. C) Currents increased with time in culture 
after puromycin selection (n=30 to 45 cells per bar). *denotes p<0.01 (Mann-Whitney rank sum 
test). 
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Figure 3.8: Sim1-Puro selected cultures present synaptic currents consistent with glutamatergic 
neurons. (A) Whole-cell current recorded at -80 mV during exposure to Tyrode’s solution 
containing elevated potassium (10 mM; KCl alone) as indicated by the open box, or 10 mM 
potassium Tyrode’s that also included 30 µM NBQX and 50 µM APV to block AMPA/kainate 
and NMDA receptors, respectively, as indicated by the filled box. Short segments during each 
exposure are shown on a 10 fold expanded time scale. (B) Plots of mean +/- sem amplitude 
(Amp, pA), frequency (freq, Hz) and width at half amplitude (half-width, msec) of synaptic 
events evoked during exposure to elevated KCl alone (open bars, 4 cells) or with 200 µM of the 
GABA anatagonist bicuculline methiodide (grey bars, 3 cells).  
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Selected Sim1-Puro cells expressed a number of neurotransmitter-gated channels, as determined 
by exposure to the inhibitory transmitters γ-aminobutyric acid (GABA) and glycine, as well as 
excitatory agonists for AMPA/kainate and NMDA receptors. Agonists were applied at  
100 µM, and the NMDA solution was supplemented with 1 µM glycine, which is required as a 
co-agonist. At a fixed holding potential of -80 mV, all four agonists evoked inward currents (Fig. 
3.7A). When the holding voltage was ramped from negative to positive potentials, the currents  
reversed polarity consistent with the ionic selectivity of their underlying ion channels. Current 
evoked by GABA or glycine reversed near -50 mV as expected for chloride selective channels, 
whereas kainate and NMDA evoked currents that reversed near zero mV, consistent with 
selective permeability to cations. These results indicate the Sim1-Puro cells are expressing 
appropriate neurotransmitter receptors.  
The data presented indicates that selected cells exhibited maturation by decreasing input 
resistance, increasing membrane capacitance, and acquiring more negative resting potentials. 
Inward and outward currents, appropriate agonist and blocker responses, and spike firing and 
spike adaptation also point to the in vitro maturation of the V3 INs. Additionally, the data 
presented within Table 3.3 suggests similar trends as the values reported in Borowska et al. [14, 
37] with the more mature Sim1-Puro V3 INs having capacitance and input resistance values that 
fall fairly close to the error range previously reported for the ventral V3 IN population [91]. A 
few differences in the cells recorded in our study deserve mention. Firstly, the ESC-derived V3 
population is likely to exhibit more rostral positional identity than the lumbar populations studied 
by Borowska et al. [91]. The use of low RA to derive V3 INs will result in a more rostral 
phenotype [166] than the lumbar population analyzed in earlier studies [14, 37]. Secondly, the 
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values previously reported for V3 INs were determined by recordings from slices and not from 
neurons in dissociated cell culture. The difference in environment may underlie modest 
differences between our results and previously reported data. Not only do the ESC-derived V3 
INs in vitro lack appropriate cues for migration, they are also deprived of physiologically normal 
pre- and post-synaptic connections. Thus, the slightly different than slice recording 
measurements observed in isolated ESC-derived V3 INs are not unreasonable.  
In addition to currents evoked by exposure to exogenous agonists, some of the selected 
Sim1-Puro cells displayed spontaneous inward currents that resembled excitatory postsynaptic 
currents observed in primary neuronal culture (Fig. 3.8). The frequency of spontaneous events 
increased substantially during local perfusion with elevated KCl (10-20 mM) to depolarize 
presynaptic terminals. Consistent with the glutamatergic phenotype of V3 interneurons, 
spontaneous currents in selected Sim1-Puro cultures were unaffected by the GABAA receptor 
antagonist, bicuculline (200 µM) but were eliminated during superfusion with a combination of 
NBQX (30 µM) and APV (50 µM), glutamate receptor antagonists that block AMPA/kainate and 
NMDA receptors, respectively [179]. These observations of spontaneous inward currents 
resembling postsynaptic currents functionally confirms the glutamatergic phenotype expected for 
V3 INs. Furthermore, these recordings at 1p +10 confirms the qRT-PCR data and indicates that 
selected Sim1-Puro V3 INs are able to mature into synapsing glutamatergic neurons.  
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3.6 Conclusion 
In this study, we have demonstrated that PAC was successfully knocked into the Sim1 
locus of a mouse ESC line. The resulting cell line allows for the enrichment of Sim1+ cells post 
induction. The selected population exhibits characteristics consistent with what is expected of V3 
INs at this stage of development. This novel cell line allows for the further understanding of an 
understudied population of spinal INs. The Sim1-Puro cell line could be useful in understanding 
IN maturation and CPG formation. Co-culturing Hb9-Puro MNs and Sim1-Puro V3 INs could be 
a starting point for a bottom-up approach to understanding CPG circuitry and ultimately 
designing novel therapeutics for spinal cord injury. 
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Chapter 4: Summary and Future Direction 
4.1 Summary of Findings 
The overall goal of this thesis was to develop scalable, high throughput methods and 
tools to lay the groundwork for future studies of excitatory and commissural V3 INs. V3 INs 
have great potential for better understanding the role of CPGs in the spinal cord and ultimately 
improvements in spinal cord injury therapy. This thesis accomplished two goals: the 
development of an induction protocol to generate V3 INs from mESCs, and the generation of a 
drug-selectable V3 IN line for the purification of ESC induced V3 INs. The successful 
establishment of a V3 IN induction protocol allows for ESCs to become a limitless V3 IN cell 
source while the generation of a selected post-mitotic V3 IN cell line allows for a highly purified 
cell culture that opens up many possibilities for future studies.   
In Chapter 2, a method to induce V3 INs from mESCs was established. A 2-/6+ V3 IN 
induction protocol used longer SAG durations and lower RA concentrations than a previously 
established 2-/4+ MN induction protocol to significantly increase expression of Sim1, a V3 IN 
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marker. The induced cultures were also positive for p3 markers Ngn3 and Nkx2.2 and post-
mitotic V3 marker Uncx. After induction, cultures had about 8% V3 INs based on Sim1 in situ 
hybridization and Uncx immunocytochemistry data. A decrease in RAX expression after V3 IN 
induction indicated that the Sim1+ identity of the induced cultures were likely not hypothalamus-
like. The results of this chapter provided insight into how to alter RA and SAG signaling to 
manipulate induction protocols towards a more ventral spinal identity.    
In Chapter 3, the issue of low V3 IN yield from the induction protocol was addressed by 
developing a selectable cell line, Sim1-Puro, in which the PAC gene was expressed under Sim1 
gene regulatory elements. Homologous recombination was used to incorporate the PAC gene 
into the open reading frame of the Sim1 gene, effectively knocking out Sim1 and knocking in 
PAC on one allele. The resulting cell line utilized the Sim1 regulatory elements to control PAC 
expression and provided puromycin resistance to post-mitotic V3 INs.  Puromycin was then used 
to kill off non-Sim1 expressing cells, resulting in the improvement of V3 IN purity. The selected 
cultures matured and exhibited physiological properties and molecular markers expected from 
V3 INs. The results of this chapter demonstrate a high throughput method to purify V3 INs from 
mESC inductions.  
Overall, the research presented in this thesis establishes a set of tools for future studies of 
spinal INs. The establishment of the 2-/6+ V3 IN induction protocol and the puromycin-selectable 
Sim1-Puro cell line provides a way to obtain V3 INs without tedious dissection from embryos. 
This thesis offers a high throughput, scalable, high purity method for obtaining V3 INs in vitro. 
Future studies can use the generated cells for better understanding the role of V3 INs in CPGs 
and reorganization after spinal cord injury.  
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4.2 Recommendation for Future Directions 
The establishment of a V3 IN induction protocol and a selectable V3 IN cell line is the 
first step towards understanding V3 INs. The electrophysiological characterization of the Sim1-
Puro cell line shows it can functionally mature, indicating in its usefulness in further V3 IN 
studies.  Additionally, the understanding of how RA and Shh work together to generate V3 INs 
compared to MNs provides insight on how to further manipulate induction protocols to generate 
other cell types or apply the V3 IN induction reported in this thesis to other cells.  Finally, the 
methods used to generate the Sim1-Puro cell lines can be applied to many other molecular 
markers to generate a wide variety of cell lines to better study V3 INs.  
  
4.2.1 Further V3 Studies 
The generated Sim1-Puro cell line allows for the purification of V3 INs from a 
heterogeneous induction. This enables better understanding of V3 INs by more precise 
controlling of the culture environment. Recording cellular activity on multi-electrode arrays can 
provide information on V3 INs’ ability to synapse onto themselves [180].  Culturing V3 INs on 
islands would allow for autosynapsing [181].  Using calcium channel dyes can also allow for 
visualization of signal propagation [182,183]. These studies would be the first steps in 
understanding V3 IN function in vitro.  
Similar studies can be performed on cocultures. Coculturing V3 INs with previously 
reported Hb9-Puro MNs and other INs could culminate in modeling CPGs in vitro. A well-mixed 
coculture of INs and MNs could allow for recordings on multi-electrode arrays to get a sense of 
clustering spikes and signal propagation. Additionally, coculturing selected V3 INs and neuronal 
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cell types within multi-chamber microdevices would allow for quantification of axonal 
growth[184-186] and even allow for unidirectional synapsing between two cell types[187]. 
Applying calcium dyes to any of the previously mentioned culture conditions could be useful for 
visually following CPG activity and further understanding the roles of different INs in CPGs 
from a bottom up in vitro approach.  
The generated V3 INs were not used for in vivo studies. The scarcity of the V3 INs after 
induction makes EBs less structurally sound than the EBs used for studying Olig2-Puro cells in 
vivo [174]. However, transplantation studies could show how efficient the induction and 
subsequent selection process is for removing teratoma causing mESCs. These assessments would 
be useful for understanding what steps and precautions may be needed for translation. Finally, in 
vivo studies could be useful to understand how and if the generated V3 INs could be beneficial to 
functional recovery after spinal cord injury.  
 
4.2.2 Additional Induction Protocols 
While V3 INs are an interesting cell population for study of CPGs and functional 
recovery after SCI, they are not the only IN population of interest. All the ventral spinal 
populations play a role in CPGs and locomotor control. MNs, V2as, and now V3s have been 
generated from mESCs. Additionally, V0s have been shown to be generated with a high RA only 
induction. However, a more comprehensive set of protocols for the generation of these 
populations would be useful. V1s as well as a variety of ventral IN subtypes are still needed. 
Additionally, as more markers for ventral IN subtypes are identified and more developmental 
pathways are elucidated, differentiation protocols for specific IN subtypes could be established. 
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For instance, DAPT was used to drive V2a differentiation preferentially over V2b differentiation 
[68,93].  This work could then be used for bottom up methods of in vitro modeling of CPG in 
addition to the mathematical models that have been previously reported[188].  
The induction method established in this work could be translated to human cell cultures. 
Due to the difference in cell types, the duration of induction would need to be extended 
appropriately to mimic the extension seen when translating the mESC MN protocol to human 
cell types[102,103]. As MN protocols in human iPSCs have demonstrated [104], a combination 
of multiple Shh pathway agonists may be useful to speed up the induction of MNs. This 
combinatorial exposure to different agonists (purmorphamine, SAG, etc) could be useful for 
generating V3 INs in human cell cultures, potentially even increasing the efficiency of the 
protocol without toxicity issues.  
 
4.2.3 Other Cell Lines 
While a drug-selectable cell line is effective for the isolation of V3 INs, knocking other 
genes into the Sim1 locus could also be useful. A lineage tracing line where Cre recombinase is 
knocked into the Sim1 locus and a flox-stopped fluorescent marker in the safe harbor ROSA 26 
site would allow for easy identification of all cells that expressed Sim1 at any point, even after 
Sim1 is turned off [111,112]. This line could be useful to see how Sim1+ cells mature within the 
context of supportive glia that arises from the induction, as opposed to the use of glia 
conditioned media in this thesis. Furthermore, inserting a ubiquitously expressed gene for 
fluorescent proteins into the Sim1-Puro line could be useful to quickly visually differentiate V3 
INs from other cell types within mixed cultures[189]. Other V3 and p3 markers, such as Uncx 
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and Nkx2.2, respectively, could be used to generate alternative cell lines for studying V3 INs 
with Sim1 fully intact or the p3 population as a whole. These possibilities can, of course, be 
applied to any IN population.  
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